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Nomenclature 
Nomenclature used in this thesis conforms 
essentially to that of I.U.P.A.C. (as adopted 
by the Chemical Society). The only divergence 
made has been in the case of theophylline 
derivatives. With these compounds substitutive 
forms of the trivial name have been used for 
clarity and convenience in preference to the 
more unwieldy systematic nomenclature. 
iii 
Summary 
The syntheses and reactions of some 2- and 
8-substituted purines are reported in this thesis. 
Part I is concerned with work relating to the 
direct C-8 alkylation of purines, in particular, 
reactions involving theophyllines. Interest in 
this topic arose from observations made of the 
biological action of aromatic carcinogens in which 
the latter have been shown to form covalently linked 
adducts with the 8-position of the purine bases in 
DNA. Studies were initiated with the aim of 
galnlng some insight into the conditions which would 
favour the formation of 8-alkylpurines by direct 
attack at the 8-position of the purine. 
Initially, two alkylation experiments in the 
literature were re-examined. In these, the action 
of benzyl and crotyl halides on theophylline was 
reported to have given the corresponding 8-alkyl-
theophyllines among the products. The benzylation 
· 1 V 
experiment, when repeated under the reported conditions, 
gave in addition to the expected 7-benzyltheophylline 
small amounts of 8-benzyl and 7,8-dibenzyltheophylline. 
This result substantiated the fact that the direct 
C-8 alkylation of theophylline under the alkaline 
alkylating conditions does occur to some extent. 
In the light of current publications which 
describe alkylation at the 8-position of purine 
by alkyl radicals, comparative studies have been 
carried out on the benzylation of theophylline 
under continuous irradiation by U.v. light. 
Under these conditions, which do not preclude the 
possibility of benzyl radicals being present, 
preliminary results show that the yield of 
8-benzyltheophylline is significantly increased. 
From these data it is postulated that the formation 
of the 7,8-dibenzyltheophylline occurs through a 
radical benzylation at the 8-position which is 
then followed by a thermally controlled alkylation 
at the 7-position. 
v 
The reaction of crotyl bromide with theophylline 
has been similarly investigated. When the original 
alkylation was repeated the findings of the original 
workers, who reported that only 8-crotyltheophylline 
was formed, were confirmed. 
A further example of C-8 alkylation arlses 
from the methylation of 2-methylthiopurine wi th 
diazomethane which has been claimed to give as a 
minor product the dimethylated derivative, 7,8-dimethyl-
2-methylthiopurine. While the minor product is 
undoubtedly formed through an 8-methylation of 
2-methylthiopurine the above derivative has been 
ruled out as a candidate by an una mbiguous synthesis 
made of this particular purine . . 
On the synthetic aspects considerable endeav-
ours have been made towards the synthesis of various 
benzyl derivatives of theophylline encountered in 
vi 
the benzylation studies. From this work has emerged 
quite a number of interesting observations on the 
unexpecte d behaviour of benzyl groups attached to 
either pyrimidine intermediates or to purlnes. 
These include removal, rearrangement and involve-
ment of such groups in ring-closure reactions. 
Part II deals with the syntheses of some 
2-cycloalkylamino-6,9-dimethylpurines which were 
required for biological testing as amplifiers of 
phleomycin. 6,9-Dimethyl-2-(piperidin-l-yl )purine 
was found to be the most active of the purines 
which had been synthesised for the programme. 
From the data obtained with the purines tested so 
far, no rationale can be given for the effects of 
structure variation on the biological activity of 
the purine derivatives. 
Part III of this thesis is devoted to 
exploring the versatility of tetraethoxymethane, 
and to a lesser extent the tetramethoxy and tetra-
propoxy analogues, as cyclising agents in the Traube 
synthesis of 8-alkoxypurines from 4,5-diaminopyrimidines. 
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Also, the mode of cyclisation of 4,5-diamino-
6-substituted-aminopyrimidines with tetraethoxy-
methane is compared with the products derived 
from use of orthoester type reagents. With the 
results obtained to date it has been found that 
the tetraalkoxymethanes behave more like the 
general cyclising agents and afford the appropriate ' 
9-alkyl-8-ethoxyadenines rather than the isomeric 
6-alkylamino-8-ethoxypurines as is the case with 
the orthoesters. 
PART I. Studies Relating to Alkylation of 
Purines at the 8-Position 
A. INTRODUCTION 
General 
Purines as a class of heterocyclic compounds 
are of considerable significance because of their 
occurrence in all forms of living matter. It is not 
surprising therefore that these compounds have been 
the subject of intensive biological, biochemical and 
chemical investigation. 
The name and numbering of the purine ring (1) 
are due to Emil Fischer who first proved the structure 
6 
1N~ 2l 
N 
3 
( 1 ) 
of the parent compound by an unambiguous synthesis 
(Fischer and Ach, 1897). Although both are still 
retained the numbering is, however, unsystematical 
as far as the general rules for fused heterocycles 
apply. Under these rules it is more precisely 
defined as an 7(9)~-imidazo[4,5-~]pyrimidine. 
The ring system is essentially a combination 
of a n-electron deficient pyrimidine ring and a 
n-electron excessive imidazole ring. A resultant 
effect of this is an electron redistribution with the 
localisation of the n-electrons in the area of the 
1 . 
rlng nitrogen atoms; the adjacent carbon atoms as a 
consequence show a great deal of electrophilic 
character. This property varies quite considerably 
with the position of the carbon atom in the ring and 
is also greatly influenced by the presence of other 
2 . 
groups in the ring. Studies (Sutcliffe and Robins, 1963) 
carried out on nucleophilic displacement of chlorine atoms 
at the 2-, 6- and 8-positions indicate that for the 
unionised molecule, the 8-carbon atom seems to be the 
most electron deficient and substituents at this position 
are displaced first, the overall order of reaction being 
C-8, then C-6 and lastly C-2. 
In spite of the preceding remarks concerning 
the electrophilicity of the 8-carbon atom this position 
can also show equally marked nucleophilic character. 
This occurs if two more electron releasing groups are 
present in the molecule, the effect of these being to 
compensate for the TI-electron deficiency in the 
pyrimidine moiety and thereby restore the TI-electron 
excessive character of the imidazole ring. Attack at 
C-8 by electrophiles now becomes possible, this being 
shown by the fact that direct halogenation, nitration 
and diazotisation can be effected with many purines. 
Historical 
The demonstrated nucleophilic character of 
the 8-position of some purines, noted above, has also 
biological significance when viewed in the light of 
reports which have appeared recently concerning the 
possible mode of action of aromatic carcinogens. 
In these it is suggested that the carcinogen, in 
the form of carbocation, acts as an alkylating agent 
towards the purine bases, in particular guanine 
(Kriek, 1972)~of the nucleic acid. The results of 
these studies, both in vivo and in vitro, show that 
alkylation at C-8 is the major reaction involving the 
guanine moiety. This is seen in the isolation of the 
stable carcinogen-purine adduct (A) when acetyl amino-
fluorene (B) is the carcinogenic agent used (Scheme 1). 
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3 . 
This case of f-alkylation, i.e. an apparent 
direct electrophilic attack at C-8, is not we ll 
supported by other such examples in the lit erature. 
On theoretical grounds this i s unexpected as under 
the usual alkaline alkylati ng conditions an 
N-9(7)-unsubstituted purine undergoes reaction in the 
anionic form. In this event both nitrogen atoms and 
the 8-carbon atom of the imidazole ring would be 
expected, because of charge lo calisation, to show some 
nucleophilic character. In practice, however, examples 
of C-8 alkyl derivatives being formed a s a result of 
~-alkylating procedures carried out in alkaline media 
are very rare. 
Before further elaboration of this aspect, 
however, it is pertinent to point out that although 
converSlons of 8-unsubstituted purines to 8-alkyl-
purlnes have been achieved by heating the former with 
varlOUS acylating reagents e.g. acids, anhydrides, or 
acid amides, these are not examp l es of f -a lkylati on 
but involve Traube-type condensations. In reactions 
' of this kind an opening of the imidazole ri ng occurs 
initially with the resulting 5-amidopyrimidine 
undergoing subsequent deacylation to the corresponding 
4,5-diaminopyrimidine. The latter is then reacylated 
by the reagent and thermal recyclisation to the 
8-alkylpurine then follows (Scheme 2}. 
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Although it has been shown r ec ently that 
alkyl radicals will smooth l y convert 8 -unsubstituted 
p"ri nes to the corresponding 8-al kyl ho mol ogue s-,there 
are in the literature one or two exa mpl es of ~-alkyl-
ation which have taken pl ace under cond i tions wh i c h 
favoured ionic rather than radical interactions. In 
one of th e se (Donat and Carstens, 1959) following 
5 . 
NH2 
NH2 
treatment of the sodium salt of theophyl l ine with crotyl 
bromide (MeCH=CH-CH 2Br), at room temperature in aqueous 
solution, the sole product obtained i s 8-crotyltheophylline. 
In this reaction it is so mewhat surpris i ng to find the 
absence of any N-7 alky l ation in view of the facility 
with which theophylline usual l y gi ves only a 7-alkyl 
derivative under alkaline conditions. 
An apparently similar case of direct 
C-8 alkylati on in the literature (Serchi, Sancio and 
Bichi, 1955) is encountered in the benzylation of 
theophylline with benzylchloride. From the reaction 
both 7-benzyltheophylline and an isomeric product, 
presumed to be the C-8 benzylated theophylline, are 
claimed to have been isolated. The physical data 
reported in support of the latter product are, however, 
not in accord with those derived from authentically 
prepared 8-benzyltheophylline. 
Present Work - Objectives and Scope 
As the aim of the present studies was to 
attempt to gain insight into the reaction conditions 
which would predispose towards f-alkylation of purlnes, 
the initial step was to check the authenticity of the 
results of the two alkylation attempts on theophylline, 
noted above. 
Although the experimental conditions employed 
would be expected to favour an ionic type of mechanism 
operating, there are a number of current publications 
.in which alkylation at C-8 by alkyl radicals is 
reported to be both facile and to give good yields. 
With this aspect in mind, comparative studies were also 
made in which continuous irradiation by ultraviolet light 
was carried out during the alkylation procedure. Under 
these conditions, which favour alkyl radical formation, 
an lncrease in 8-alkylpurine formation would be expected 
to occur. 
6 . 
The remaining case reported (Brown and Ford, 
1969) of direct C-8 al kylation, occurring under 
alkaline alkylating conditions, is from the methylation 
of 2-methylthiopurine with diazomethane whe n in addition 
to the major product, the expected 9-methylated pur l ne, 
a minor product, formulated as ~,8-dimethyl-2-methyl-
thiopurine is obtained. Because the evidence given 
by the original worker s supported the idea that the 
latter was most likely the unknown 7,8-dimethy1purine 
this point was investigated as part of the programme. 
An unambiguous synthesis of this purine was carried out 
and a comparison made of the data from both dimethy1ated 
compounds. 
Considerable endeavours were made on the 
syntheses of the various benzyl derivatives of 
theophylline encountered in the work. In some cases, 
in spite of prolonged efforts, the required derivative 
was not obtained due to adverse and somet im es unexpected 
reactions occurring. Notable among these were a 
number of examples in which loss or rearrangement of 
benzyl groups was involved. An interesting example of 
this was encountered during the attempted synthesis of 
8,8-dibenzyl-8~-theophylline. This derivative, if 
obtained, was expected to follow the reaction pattern 
of other 8,8-dia1kyl-8~-purines and rearrange to the 
7,8-dibenzyl analogue. However, in practice 8-benzyl-
theophylline was the only product obtained; no 
8,8-dibenzyltheophylline being detected. 
7 . 
At this stage, therefore, the scope of 
the work was broadened to include not only studies 
related to attack at C-8 of the purine but also 
investigations of the reactivity of the C-8 position 
towards the entry and departure of benzyl groups and 
the migration of benzyl groups lo cated on imidazole 
ring nitrogen atoms. Inclusion of these additiona.l 
topics in the programme was felt to be apposite to 
the problem of f-alkylation in view of cases of alkyl 
group migrations from C-8 to N-7 having been reported 
in purines. Thus, it was hoped that data from 
experiments in which group loss or rearrangement was 
experienced would, perhaps, throw more light on the 
mechanism of the f-alkylation reaction. 
8 . 
B. ALKYLATION STUDIES 
a. Benzylation of theophylline 
Serchi and coworkers (1955) carried out the 
benzylation of theophylline (1) with benzyl chloride 
in the presence of an equimolar amount of aqueous 
sod ~um bicarbonate using a temperature of around 100 0 . 
Alkylation of theophylline und e ~ these conditions 
normally gives only a 7-alkylated derivative but in 
9 . 
this case, as well as the expected 7-benzyltheophylline 
(2) in 65% yield, a further product (22%) was obtained 
from the mother liquors. As the analysis of the latter 
showed it to be isomeric with the 7-benzyl derivative 
(2), it was suggested that it was 8-benzyltheophylline 
(3). This was a known compound which had been 
synthesised unambiguously by Hager and Krantz (1954) by 
fusing 4,5-diamino-1,3-dimethyluracil with phenylacetic 
acid and then cyclising the phenylacetamidopyrimidine 
in alkali (Scheme 3). A comparison of the physical 
data for the authentic purine with that reported by 
Serchi et al. for their isomer, however, showed no 
agreement. For example, the melting point of 8-benzyl-
theophylline (289 0 ) is some 40 0 higher than that 
reported by Serchi for his product. In addition, he 
reported that 7-benzyltheophylline and the . . lsomerlC 
derivative had the same Rf values in three different 
solvent systems; this was somewhat unusual considering 
the more polar nature, due to the ionisable proton in 
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the imidazole ring, of 8-benzyltheophylline. At no 
stage did Serchi and his coworkers appear to consider 
the possibility that the isomeric product was the 
9-benzylated derivative (4). This attitude was, no 
doubt, influenced by the fact that no 9-alkyltheo-
phylline has so far resulted from direct alkylation 
of theophylline. Conclus i ve evidence, however, that 
the unknown isomer was not the 9-benzylated purine (4) 
was provided the following year (Blicke and Schaaf, 
1956) when this derivative was also unambiguously 
synthesised. 
It was thought desirable, therefore, to 
repeat the benzylation experiment under the reported 
conditions in order that, firstly, the formation of 
another product from the alkylation procedure could 
be verified and, secondly, to ascertain, if such a 
product was formed, if this arose as a result of a C-
rather than an N-alkylation reaction. 
10. 
Following the alky l ation of t heophylline 
under the reported conditions the solid which separated 
out was then treated with alkali to dissolve any 
8-benzyltheophylline present together with any 
unreacted theophylline; the residue, which was the 
m a j 0 r pro d u c t, was r e cry s tal 1 i sed :: rom e t han 0 1 9 i v i n 9 
the 7-benzyl derivative (2). From the alkaline filtrate 
a solid, identified as 8-benzyltheophylli ne (i.r., n.m.r., 
t.l .c.), was precipitated on acidification. 
11. 
The mother liquors obtained from crystall-
isation of the alkali-washed crude reaction product, 
after suitable concentration, were run on a silica 
preparative t.l.c. plate, three bands being observed. 
Each band wa s extracted separately with hot chloroform 
and the extracts evaporated down. The product from 
the bottom band corresponded to unreacted theophylline, 
the middle one was due to 7-benzyltheophylline while 
the upper band gave an unknown product, m.p. 120-121 0 . 
Elementary analysis of this low m.p. material 
corresponded to that of a dibenzylated theophylline 
derivative. As this was not a salt, the quaternary 
form (5) could be excluded. Examination of the 1H n.m.r. 
spectra revealed that the 8-H proton signal was absent 
from which it was inferred that one of the benzyl groups 
might be occupying this position. The location of the 
second benzyl group was, therefore, either at N-7 or 
N-9, with the former more favoured in view of the 
alkylation mode of theophylline in which the 7-alkylated 
analogue is always the preferred product. These 
suppositions were subsequently confirmed when the 
1H n.m.r. spectra (Figure 1, 0 values in DMSO with TMS 
internal standard) of 7-benzyl-, 8-benzyl-, and 9-benzyl-
theophylline were compared. In particular the chemical 
shifts of the benzylic protons (-CH 2-) due to the 
7-benzyl (Figure 1a) and 3-benzyl derivatives (Figure 1b) 
showed the best correspondence with t he two separate 
benzylic protons of the dibenzyl analogue (Figure 1d). 
A further significant feature in identificatio n of 
the position of the second benzyl group was the 
nature of the phenyl group proton signals. In both 
7-benzyl- and 8-benzyl-theophylline the same singlet 
signal was shown; this also being the case with the 
dibenzylated purine, whereas in the 9-benzyl 
(Figure lc) and 9-benzyl-8-substituted-theophyllines, 
extensive multiplicity was found. Chemical shifts 
for the above and related derivatives are given in 
Table 1. Thus, it seemed that the unknown derivative 
had the 7,8-dibenzyl (6) rather than the 8,9-dibenzyl 
(7) configuration. Virtually conclusive proof for 
the former assignment was the isolation of 7,8-dibenzyl-
theophylline (6) when the sodium salt of 8-benzyl-
theophylline (3) was treated with benzyl bromide. The 
two dibenzyl derivatives were shown to be identical in 
their m.p., i.r., IH n.m.r., u.v., t.l.c., and 
analytical data. 
When the benzylation of theophylline was 
carried out at room temperature (12 h) mainly starting 
material was isolated; only trace amounts of 7- or 
8-benzyl-theophylline could be detected by t.l .c. 
In summation, therefore, it can be said 
that the repeat of the benzylation of theophylline, 
under the conditions reported by Serchi et ~., has 
not given the same results; no product with physical 
data corresponding to their "8-benzyltheophyll ine ll 
12. 
13 . 
being isolated. In addition to the expected 
7-benzyltheo phylline (36 %) the two minor products 
obtained were authentic 8-benzyltheophylline (0.8%) 
and a new derivative, 7,8-dibenzyltheophylline (0.4 %). 
Interpretation of the original workers' 
results in the light of the findings from the repeat 
benzylation experiments are difficult. The product 
erroneously claimed to be 8-benzyltheophylline would 
seem to be most likely an impure specimen, especially 
if we consider that the quoted m.p. from ethanol 
(248-249 0 ) rises to 256 0 on recrystallisation from 
pyridine. These figures contrast sharply with 
the figure (289-290 0 ) given for aut he ntic 8-benzyl-
theophylline (Hager and Krantz, 1954). In view of 
the lack of further specific physical data, l.e. u.v., 
1 .r., or 1H n.m.r., for the unknown derivative it is 
suggested by way of explanation that some 8-benzyl-
theophylline is present but this is contaminated with 
both the 7,8-dibenzylated homologue and unreacted 
theophylline, a fortuitous rat io of the last pair 
giving rise to the satisfactory analysis figures for 
the IImonobenzylatedll product. 
In view of the fact that the analytical 
data given by Serchi and coworkers were for monohydrated 
not anhydrous forms of the benzyl purines consideration 
was also given to the possibility that the unknown 
monobenzyl derivative was not a purine - but 6-amino-5-(~­
benzyl )formamido-1,3-dimethylpyrimidine-2,6-dione (8), 
14. 
which has the same empirical formula . Under the 
alkaline reaction c o ~ ditions this could easily arlse 
through ring-opening of 7-benzyltheophylline. Many 
N-7 or N-9 alkylpurines undergo attack at C-8 by 
hydroxyl ions, with subsequent fission of the imidazole 
ring, a result which reflects their inability to assume 
the more stable anionic form. In order to test this 
possibility 7-benzyltheophylline was heated under 
reflux with an equimolar amount of sodium hydrogen 
carbonate solution for some hours. No evidence of 
a ring-opened derivative was obta i ned, only starting 
material in good yield was recovered. This result, 
therefore, virtually rules out the possibility that 
the 118-benzyltheophylline monohydrate ll of Serchi contains 
any of the isomeric 5-(~-benzyl )formamidopyrimidine (8). 
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Table 1 
1H N.m.r. spectra of Theophylline derivatives 
(8 values in DMSO, TMS as internal standard) 
o 
MeN 1 ~ 3 
o N 
Me 
, 
N 
:)8 
N 
I 
16. 
Substituent CH 2 
(benzyl) 
C6H5 Me(N 1), Me(N3) 8-H 
None 
7-benzyl 
8-benzyl 
9-benzyl 
7,8-dibenzyl 
9-benzyl-8-benzylthio 
9-benzyl-8-thio 
8-phenyl 
7,8-dibenzylxanthine 
5.45 (N7) 
4.05 (C8) 
5.65 (N9) 
5.55 (N7) 
4.10 (C8) 
5.50 (N9) 
4.40 (S) 
5.83 (N9) 
5.37 (N7) 
3.92 (C8) 
3.47,3.25 8.05 
7.30 3.39, 3.19 8.27 
7.31 3.41, 3.23 
7.30 (m) 3.40, 3.20 7.83 
7.17 3.40, 3.20 
7.30, 7.0 3.38,3.23 
7.4 (m) 3.40, 3.20 
8. 12, 7.48 3.50, 3.27 
7.18 
17 . 
b. Benzylation of theophylline under U.V. Irradiation 
In the benzylation experiments described 
earlier in section (lBa) theophylline is presumed to 
react in the anionic form and undergo attack by benzyl 
cations. Quite a substantial number of publications 
have, however, appeared recently (Christensen et al., 
1975; Maeda et al., 1974; Leonov and Elad, 1974; 
Jerumanis and Martel, 1970) concerning the direct C-8 
alkylation of purines under conditions which favour 
formation of alkyl radicals rather than cations. 
In view of these findings, which demonstrated 
that alkyl radicals can be formed and react under very 
mild conditions, some preliminary benzylation experiments 
were conducted using procedures which promote benzyl 
radical formation. It was expected that if radicals 
were formed then there would be an increase in the 
yield of 8-benzyltheophylline. For this purpose, 
therefore, the alkylations were repeated but with 
irradiation by ultraviolet light being maintained 
throughout the experiments. Although it was not 
practical to attain the original benzylation conditions 
exactly, for example the highest temperature at which 
the irradiation could be carried out was 90 0 compared 
with the reflux temperatures employed in the normal 
benzylation, some significant results were obtained. 
Both longwave (350 nm) and shortwave (254 nm) 
ultraviolet light was used and Pyrex apparatus was 
extensively employed. This type of glassware is 
reported to be impervious to shortwave u.v. light 
below 310 nm and to overcome this difficulty some 
parallel reactions were carried out using the 
18 . 
longer wavelength (355 nm) u.v. radiation. It was, 
therefore, interesting to compare the results 
obtained with the two different radiation sources 
with those from the experiments performed in visible 
light. The results given in Table 2, show the 
weight of products isolated using an initial weight 
of 5 g of theophylline for each reaction; this was 
converted into the soluble sodium salt either before 
or during the reaction. 
Before comparing the results of the visible 
light and u.v. light procedures account must be taken 
of the amount of starting material which remains at 
the end of each experiment. Whereas only a small 
quantity (25-30%) is recovered under the normal 
alkylating conditions this figure approximates to 
.50% when irradiation is employed. Thus, the yields 
of benzylated derivatives must be viewed against the 
actual amount of theophylline consumed in the reaction. 
On the basis of these facts then it can be demonstrated 
that the 0.5% overall yield of the 7,8-dibenzylpurine 
formed in visible light (100 o/4h) rose to 1.2% (90 o/12h) 
in the presence of 350 nm light. However, in shorter 
wavelength light, little or none of this derivative can 
be detected. More interesting results are obtained 
for the formation of 8-benzyltheophylline where the 
visible light value of 0.8 % (74 0 /12h) rises nearly 
twentyfold to a significant 14 % under the same 
conditions but in the presence of 254 nm radiation. 
In this case time and temperature appear to have a 
degradative effect as the yield of this isomer drops 
to half of the above figure when the irradiation 
proceeds for 24 hat 90 0 . It is of interest to find 
that along with the increase in the 8-benzylpurine 
under irradiation there is a corresponding decrease 
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in the normal alkylation product, 7-benzyltheophylline. 
This falls from the visible light value of 36 % 
(74 0 /12h) down to 26 % using short wavelength treatment 
with the same time and temperature. If these conditions 
are intensified or prolonged, then, as in the case of 
the 8-benzyl isomer, i.e. at 90 0 /24h, the yield drops 
further to about one half of this figure. 
The most significant feature that is noted 
from these results, when viewed overall, is the 
marked increase in the yield of 8-benzyltheophylline 
under irradiation, together with the reduction, to a 
lesser extent, in the formation of the normal 
7-alkylated product. In view of the tendency of 
radicals for C- rather than N-substitution these 
findings lend support to the idea of a radical rather 
20. 
Table 2 
Benzylation of theophylline (5 g) with benzyl halide in aqueous alkali 
Radiation Reaction Products Unreacted 
cond iti ons 7-benzyl 8-benzyl 7,8-dibenzyl theophylline 
Visible 21°,12h * 0.01 9 
74°, 12h 2.3 
100°, 4h 2.5 
U.v.(350 nm) 90°, 12h 1.0 
U.v.(254 nm) 74°, 12h 0.8 
90°, 6h 0.7 
90°, 24h 0.4 
- - - - - -
74°, 12h 
* Yields from 1 9 theophylline only. 
* trace 
0.05 
0.08 
0.15 
0.50 
0.26 
0.14 
0.04 
0.06 
possible 
trace 
possible 
trace 
* 0.7 
0.7 
0.5 
2.5 
2.4 
2.4 
2.3 
- - - - - - - - - - - - - - - - - -
4.0t 
t theophylline, as neutral molecu l e, in 50% aqueous acetone. 
-
ionic mechanism operating in the formation of the 
8-benzyl derivative. 
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It was expected, in view of the isolation 
of some 7,8-dibenzyltheophylline during the original 
(visible light) benzylation procedures, that under 
the u.v. light conditions this yield would be 
significantly increased. In fact, this did appear 
to occur to some extent with the long wavelength 
u.v. light but not at all, or possibly only in trace 
amounts, with the shorter wavelength light. 
No clear cut rationale can be advanced to 
explain the production of the 7,8-dibenzyl homologue. 
The results from the visible light experiments suggest 
that in the formation of this derivative a temperature 
effect operates; this is also discussed in a later 
section (lCa). Thus, after benzylation for 12 h at 
74 0 none of the dialkylated purine can be detected 
whereas some is found to be present after 4 h at 1000 . 
Therefore, the relatively small increase in yield 
following long wavelength u.v. irradiation may be due 
only to a time rather than a photochemical effect. 
It would be reasonable then, in view of these findings, 
to suggest that initial formation of the 8-benzyl 
derivatives takes place by a radical attack, this 
purlne then undergoing a much slower ionic benzylation 
at N-7 because of the moderate temperatures involved 
(see Section lCa). A fact which still awaits 
clarification is the absence of any dibenzylated 
product when the short wave light is employed even 
though these conditions have given the highest 
y i elds of the 8-benzyl derivative. 
Notable also was the failure of 7-benzyl-
theophylline to undergo benzylation at C-8 when 
treated with benzyl bromide in sodium hydrogen 
carbonate solution (74 o/12h) under short wavelength 
irradiation. It seems, therefore, that similar 
considerations to those given for the benzylation of 
8-benzyltheophylline at N-7 could apply. Thus, 
because of steric hindrance due to the benzyl group 
already present, more severe reaction conditions 
than those used are needed to allow the second 
benzyl group to be inserted. 
The gradual decrease in the yield of both 
7- and 8-benzyltheophylline that is found to occur 
with prolonged exposure to short wavelength light 
at elevated temperature is presumed to be due to 
photolytic degradation. Examples of fairly rapid 
breakdown of xanthine derivatives in solution are 
recorded (Matsuura and Saito, 1967) following 
exposure of them to ultraviolet radiation. 
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c. Action of crotyl bromide on theophylline 
An unusual but nevertheless authentic case 
of direct C-8 alkylation, reported by Donat et ~. 
(1959), arises when sodium theophylli nate is treated 
with crotyl bromide at room temperature (Scheme 4) 
giving 8-crotyltheophylline (9) as the sole product .. 
It is surprising to find the absence of any N-7 
alkylated product (10) in view of the ease with which 
theophylline usually gives the 7-alkyl derivatives 
under such conditions. 
This second example reported of unexpected 
reactivity of the 8-position in theophylline prompted 
also the re-examination of this alkylation as an 
extension of the previous benzylation studies. When 
this experiment was repeated, under the conditions 
originally employed a white precipitate was obtained. 
On crystallisation, a sample of this gave 8-crotyl-
theophylline; the m.p. and n.m.r., of which were in 
agreement with those of the authentic derivative 
which had been obtained by an unambiguous synthesis 
(Donat, 1959). In order to find out if there was 
any N-7 alkylated theophylline present the precipitate 
was digested with alkali. However, no trace of the 
insoluble N-7 alkyl derivative could be found. 
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Scheme 4 
This was further confirmed by t.l.c. examination. 
These results, therefore, confirmed the original 
workers· findings. 
The formation of only 8-crotyltheophylline 
from the reaction of t he ophyll ine with crotyl 
bromide under remarkably mild conditions is abnormal. 
Nothing definite can be proposed regarding the 
mechanism from the evidence availab le at present. 
Deuterium exchange reactions have be en reported 
(Steinmaus, Rosenthal, and Elad, 1969) and these 
experiments show the tendency of the C-8 proton to 
exchange readily. It could be argued, therefore, 
that because of this tendency the substitut i on at 
C-8 takes place. Since, however, this is not found 
to be the case with every theophyll in e or purine 
derivative, this reasoning does not hold and another 
explanation has yet to be found. 
24. 
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c. ATTEMPTED SYNTHESIS OF 7,8-DIBENZYLTHEOPHYLLINE 
After having shown almost conclusively that 
the dibenzylated prod uct, obtained during the benzyl-
ation of theophylline, was 7,8-dibenzyltheophylline, 
it remained at this juncture of the work to provide 
confirmatory proof by carrying out an unambiguous 
synthesis. During the va rious attempts made at this, 
which are described below, quite a number of inter est-
lng reactions were encountered. 
a. From 8-benzyltheophylline 
Initially the benzylation of 8-benzyltheo-
phylline in aqueous alkaline solutio n was tried under 
the same conditions as were employed to form 7-benzyl-
theophylline. At the end of the reaction, however, 
only the starting material was recovered. At this 
stage, it was considered that this might be due to 
steric hindrance by the 8-benzyl group towards the 
approach of the benzyl moiety at the 7-position. It 
was thought, therefore, that more forcing conditions 
should be tried to overcome any such steric effect. 
For this purpose the benzylation of the sodium salt 
of 8-benzyltheophylline was attempted with benzyl 
chloride in dimethylformamide under reflux conditions. 
Upon completion of the reaction the solid product 
obtained was found to have the same m.p., 1 .r., n.m.r., 
t.l.c. and analysis as the dibenzylated product obtained 
from the benzylation of theophylline. Since, as 
has been noted already, derivatives of theophylline 
under alkaline alkylating conditions give only N-7 
alkyl derivatives, it was concluded that this product 
was 7,B-dibenzyltheophylline. This benzylation 
result therefore, confirms that one of the benzyl 
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groups is occupying the B-position in the dibenzylated 
product obtained during the benzylation of theophylline. 
However, this alkylation product has not been derived 
from a truly amb i guous synthesis and other routes were 
therefore sought to achieve this. 
b. From 5,6-diamino-l,3-dimethylpyrimidine-2,4-dione 
This approach involved initially the formation 
of a 6-amino-5-benzylaminopyrimidine which it was then 
hoped could be cyclised to the required purine using 
Traube type conditions (Scheme 5). The key starting 
material, 6-amino-5-benzylamino-l,3-dimethylpyrimidine-
2,4-dione (13), was obtained with difficulty ~ y 
catalytic reduction of the Schiff base (12) derived 
from 5,6-diamino-l~3-dimethylpyrimidine-2,4-dione (11) 
and benzaldehyde (Traube and Nithack, 1906). A number 
of attempts were made to cyclise the intermediate 
pyrimidine (13) derivative, using either phenylacetic 
acid or phenyl acetamide as the cyclising agent, but in all 
cases the product obtained was B-benzyltheophylline (3). 
This indicated unusual reactivity of the benzyl group 
and that a loss of a benzyl group had occurred either 
26a. 
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Scheme 5 
from the 5-amino group in the pyrimidine (13) or if 
it had been formed, from the 7,8-d ibenzylpur ine (6). 
Even more surprising was the is olat ion of 8-phenyl-
theophylline (14) when benzyl cyanide was used as a 
cyclising ag ent. This reaction was not further 
investigated and is still not clear. 
c. From 5,6-diaminouracil 
27. 
There are numerous examples in the literature 
ln which considerable differences in reactivity are 
shown between the same group situated on a uracil or 
the 1,3-dimethylated analogue. The former pyrimidine 
derivatives usually show the greater all round stability 
and lower group reactivity. Using these pro pe rties it 
was considered that a possible synthetic approach to 
the dibenzyl derivative (6) wou ld be to repeat the 
procedures given in the pre vi ous section (see Scheme 5) 
but using 5,6-diaminouracil as the starting material. 
Then, if conversion to 7,8-dibenzylxanthine (17) could 
be made it should be possible to methylate both ring 
nitrogen atoms to give the required theophylline (6). 
The intermediate 6-amino-5-benzylaminouracil 
(15) was obtained by the sodium amalgam reduction of the 
Schiff base derived from 5,6-diam in ouracil and benzaldehyde 
using the method of Traube (1923). This gave superlor 
yields of reduced compound compared with those obtained 
with the corresponding ~~'-dimethylated homologue using 
catalytic hydrogenation (see previous sec tion) . 
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Unfortunately, the insolubility of the dimethyluracil 
derivative (12) in alkali made the amalgam reduction 
unsuitable in this case. The fusion of 6-amino-5-
28. 
benzylaminouracil with phenylacetic acid readily gave 
6-amino-5-(~-benzyl)pheny l acetamidopyrimidine-2,4-dione 
(16). Altho ugh various high boiling solvents were 
employed in attempts to cyclise this intermediate, the 
ring closure was only successful when carried out in 
hot sodium hydroxide, this converting it into 
7,8-dibenzylxanthine (17). The latt er purine was 
found, surprisingly, to be only weakly soluble ln 
alkali and possibly because of this could not be 
methylated under the normal cond iti ons employed (methyl 
sulphate in sodium hydroxide) to the required 
7,8-dibenzyltheophylline (6). 
d. Through 8,8-dibenzyl-8H-xanthines 
The synthesis of a number of 8,8-dialkyl-8~­
xanthine derivatives (lipseudoxanthines ll ) has been 
reported (Goldner, Dietz, and Carstens, 1966). These 
derivatives have the property of isomerising at their 
melting points to give 7,8-dialkylxanth in e derivatives 
(Scheme 6). Such a rearrangement is not unexpecte c ln 
view of a report some years' earlier by Weiss (1952) ln 
which some 2,2-dialkylimidazoles, including the 
2,2-dibenzyl-4,5-dipheny limid azo l e (18), rearranged to 
give the corresponding 1,2-dialkyl-4,5-diphenylimidazole, 
the dibenzyl derivative (18) forming the isomer (19) when 
heated or treated with acids. 
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Since the main attempt to synthesise 
7,8-dibenzyltheophylline directly had failed, due to 
the loss of a benzyl group at the Traube cyclisation 
stage (Section 1Cb) it was felt that an attempt at 
the synthesis and study of the isomeric 8,8-dibenzyl-
8~-xanthine might be of use, as this derivative should 
isomerise under thermal conditions to the required 
7,8-dibenzyltheophylline. 
A number of possible routes for the 
syntheses of 8,8-dialkyl-8~-xanthine derivatives were 
contemplated, those attempted are described below. 
From 5,6-diamino-1,3-dimethylpyrimidine-
2,4-dione -- One group of workers have synthesised 
8-substituted purines by reacting the appropriate 
diaminopyrimidine and the bisulphite product of the 
aldehyde (Ridley, Spickett, and Timmis, 1965). The 
general mechanism proposed by these wor kers for the 
reaction, shown in Scheme 7, involved an intermediate 
7~,8~-dihydropurine which then underwent subsequent 
ln situ oxidation to the purine. 
It seemed worthwhile therefore, to try the 
condensation of 5,6-diamino-1,3-dimethylpyrimidine-
2,4-dione and the bisulphite product of dibenzyl 
ketone in the hope of obtaining the required 8,8-
29. 
dibenzyl-8~-xanthine (20). This it was expected wo uld 
be formed through oxidation of the initially formed 
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dihydro analogue (21). The product actually isolated 
from the reaction was, in fact, neither the 
8,8-dibenzylpurine (22, R=CH 20) nor the 7,8-dibenzylated 
isomerisation product (6) but 8-benzyltheophyllin e 
(23, R=CH 20). This occurred with all the attempts 
made in which a variety of solvents, including methanol, 
ethanol and n-butanol, were employed. Interesting 
also was the fact that when the dibenzyl ketone itself 
was used, the same 8-benzyltheophylline was recovered 
(Scheme 8). 
As it was thought that a steric effect, 
arlslng from two bulky benzyl groups, might be 
responsible for this unusual behaviour it was decided 
to attempt the synthesis of the analogue in which one 
benzyl group was replaced by a methyl group. For 
this purpose benzyl methyl ketone was employed. The 
result, no matter whether the bisulphite adduct or the 
ketone itself was used, was the same, only 8-methyl-
theophylline (23, R=Me) was isolated (Scheme 8). The 
identity of this product was checked by carrying out 
an unambiguous synthesis. 
These results, which seeme d at first to be 
quite unusual can be compared with those, reported by 
Elderfield and Meyer (1954) for the reaction of 
2-phenylenediamine with dialkylketones. Initially, the 
elimination of water occurs to give the intermediate 
30a. 
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2,2-dialkylbenzimidazole which on heating splits out a 
molecule of hydrocarbon to yield the 2-monosubstituted 
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benzimidazole (Scheme 9). Basically, therefore, these 
results are in accordance with the r esults obtained with 
the diaminouracil derivatives with the ketones. 
A recent report (Wawzonek, 1976), of studies 
ln which 5,6-diamino-1,3-dimethylpyrimidine-2,4-dione 
(11) has been condensed with diketones, is noteworthy 
in connection with the above findings as these reactions 
did not give the expected pteridine derivatives but 
8-alkyltheophyllines instead. This result is probably 
best explained by the formation of an 8-acyl-8-alkyl-
8~-purine intermediate which would undergo ready 
deacylation to the 8-alkyl derivative (Scheme 10). 
From 6-amino-l,3-dimethyl-5-nitrosopyrimidine-
2,4-dione -- 6-Amino-1,3-dimethyl-5- ni trosopyrimidine-
2,4-dione (24) has been used quite extensively for the 
syntheses of 8-substituted purines; the reaction involves 
condensation with an aldehyde giving first an 
8~alkyl (aryl)-purine-7-oxide which can be easily reduced 
to the purine (Goldner, Dietz, and Carstens, 1966a; 
Taylor and Garcia, 1964). Taylor (1964) had isolated 
8-phenyltheophylline from a co ndensation between 6-amino-
1,3-dimethyl-5-nitrosopyrimidine-2,4-dione (24) and 
benzaldehyde in dimethylformamide. This procedure was, 
therefore, tried using the bisulphite product of 
NH2 
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dibenzylketone with the nitrosouracil (24) but the 
only product isolated was 8-benzyltheophylline (3). 
The ring closure to the purine, therefore, appeared 
to have been successful but had resulted in loss of 
abe n zy 1 g r 0 up. When the ketone itself was used, 
no condensation occurred and only the starting 
material (24) was recovered. 
In line with the results obtained by the 
prevlous workers a mechanism can be postulated ln 
which as a first step an intermediate of the type 
(25) is formed. Such derivatives have been proposed 
by Goldner (1966a) and Taylor (1964) as the inter-
32. 
mediates prior to cyclisation to the 7-hydroxypurines. 
In the case of the nitrosopyrimidine (25) an analogous 
ring closure would involve a benzyl group rearrangement 
to give an 8-benzyl-7-benzyloxypurine (pathway A, 
Scheme 11) which would require reductive removal of 
the benzyloxy group to give the product (3). The 
failure of the ketone itself to react suggests, therefore, 
that this route is unlikely and other pathways should be 
~ 
considered. In route B the nitroso group in the 
derivative (25) is reduced to an amino group by the 
bisulphite present giving a product which then cyclises 
to the 8,8-dibenzyl-8~-dihydropurine (20). An 
alternative is pathway C to this dihydropurine, by 
reduction of the nitroso group in the pyrimidine (24) 
MeN' ~NH2 
.l .,-/NH2 
o N 
Me 
( 26) 
MeN 
J~N 
CH rA ll N~C~ 2P CH20 
NH2 
Me 
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before condensation with the ketone occurs. The 
resulting Schiff base (26) would also be expected 
to ring close readily and oxidation of the pr oduct 
to the 8-benzylpurine (3) would be as described in 
Section 1Cb. 
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From 6-chloro-1,3-dimethyluracil -- Another 
approach to the synthesis of 8,8-dibenzyl-1,3-dimethyl-
xanthine was based upon the work of Goldner et ~. 
(1966 ) which showed that certain 6-alkylamino-l,3-
dimethyl-5-nitrosopyrimidine-2,6-diones, for example, 
(27), can be cyclised with loss of the elements of 
water to give 8,8-dialkyl-8~-xant h ines (28). 
It seemed quite reasonable, then, to speculate 
that if 6-(1-benzyl-2-phenyl)ethylamino-1,3-dimethyl-5-
nitrosopyrimidine-2,4-dione (27, R=CH20) could be 
synthesised then this might possibly cyclise under 
appropriate conditions to give the requ i red 8,8-dibenzyl 
derivative (28, R=CH 20). 
As a first step, 2-amino-1,3-diphenylpropane 
was prepared by converting dibenzyl ketone to the 
ketoxime, by reacting the ketone with hydroxylamine 
hydrochloride, and then reducing the ketoxime by 
hydrogenation over Raney nickel. The resulting amlne 
on refluxing with 6-chloro-1,3-dimethyluracil (29) 
gave 6-(1-benzyl-2-phenyl)ethylamino-1,3-dimethyl-
pyrimidine-2,4-dione (30, R=H). Unfortunately on 
nitrosation of this derivative, instead of the required 
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5-nitrosouracil (30, R=NO) the isomeric N-nitroso 
derivative (31) was obtained. As it was felt that 
if forcing conditions were employed, in order to 
effect nitrosation of the 5-position, there was a risk 
of removal of one of the benzyl groups, no further 
attempts at synthesis by this approach were made. 
D. ATTEMPTED SYNTHESIS OF 8,9-DIBENZYLTHEOPHYLLINE 
34. 
So far, having been unsuccessful in achieving 
an unambiguous synthesis of 7,8-dibenzyltheophylline, 
an alternative course was to atte mpt the synthesis of 
the isomeric 8,9-dibenzyltheophylline in order to rule 
this derivative out as a possible structure for the 
dibenzylated theophylline. This would provide indirect 
supporting evidence that the minor product, obtained 
during the benzylation of theophylline, was 
7,8-dibenzyltheophylline (6). 
The starting material for the proposed synthesis 
was 6-benzylamino-1,3-dimethyl-5-nitropyrimidine-2,4-dione 
(33); this was obtained quite easily by replacing the 
chlorine of 6-chloro-1,3-dimethyl-5-nitropyrimidine-
2,4-dione (32) with benzyl amine in ethanol. However, 
while the preparation of 5-amino-6-benzylamino-1,3-
dimethylpyrimidine-2,4-dione (34) by catalytic reduction 
appeared to take place readily, with uptakes of hydrogen 
of the right order for reduction of the nitro group, 
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on working up the product was found to be 8-phenyl-
theophylline (14). This occurred no matter whether 
Raney nickel or platinum was used as catalyst and 
also when alkaline ferrous sulphate was employed, 
using the method of Brown (1954), as reducing agent. 
35. 
Although these results seemed at first 
somewhat surprising there is ev i dence available in the 
literature for the formation of 8-phenyltheophylline 
under similar circumstances . In one case isolation 
of this purine (14) is reported (Goldner, Dietz, and 
Carstens, 1966a) when nitrosation of the 6-benzylamino-
5-unsubstituted-pyrimidine (35) was carried out in the 
cold. The other case which gave rise first to the 
derivative (36) which was then reduced to (35), was 
the nitration at moderate temperature of the same 
5-unsubstituted-pyrimidine (35); both these preparations 
are depicted in Scheme 12. 
These two examples of purine formation, through 
cyclodehydration involving either a 5-nitroso or 5-nitro 
group, suggest an explanation for the formation of 
8-phenyltheophylline during the catalytic reduction 
of the 5-nitro derivative (33). In converting the 
nitropyrimidine to the amino analogue the intermediate 
nitroso (37, R=NO) and hydroxyamin o (37, R=NHOH) 
derivatives are involved. As both these contain a 
highly reactive group at the 5-position the cyclisation 
could occur readily at either stage. 
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36. 
As the 5-amino-6-benzylaminopyrimidine (34) 
could not be obtained by reduction of the 5-nitro 
analogue a route using an intermediate having a 
5-amino group already in place was sought. One 
possibility considered involved transamination, this 
method of directly replacing one type of amino group 
by another has been used quite widely in the pyrimidine 
serles. In this way 6-amino-l,3-dimethylpyrimidine-
2,4-dione (38, R=H) has been successfully treated with 
various amines to give the corresponding 6-alkylamino 
(38, R=Alkyl) homologues (Whitehead and Traverso, 1960). 
It was decided to try the transamination of 5,6-diamino-
1,3-dimethylpyrimidine-2,6-dione (11), by treatment with 
a mixture of benzylamine and benzylamine hydrochloride, 
, 
in the hope of obtaining 5-amino-6-benzylamino-l,3-
dimethylpyrimidine-2,6-dione (37, R=NH 2). If this 
could be achieved then it should be possible to cyclise 
this derivative to the required 8,9-dibenzyltheophylline 
uSlng either phenylacetic acid or phenyl acetamide. 
When the transamination was attempted the 
product obtained was, unexpectedly, 8-phenyltheophylline 
(14) instead of the required 5-amino-6-benzylamino-l,3-
dimethylpyrimidine-2,6-dione (37, R=NH 2). While this 
reaction was not further investigated the most logical 
explanation would seem to be that, following transamin-
ation of the 6-amino group by the benzyl amino group 
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taking place, an oxidative ring-closure occurred under 
the thermal conditions of the procedure. One possible 
reaction sequence for this would be the formation first 
of the 5-amino-6-benzylideneaminopyri mi dine (39), this 
being followed then by a ring-closure involving a second 
oxidation step to give 8-phenyltheophylline . 
. A further approach to the synthesis of the 
required 5-amino-6-benzylaminopyrim i dine (37, R=NH 2) 
37. 
was made by first preparing 6-benzylamino-5-bromo-
1,3-dimethylpyrimidine-2,6-dione (37, R=Br) from 
6-benzylamino-1,3-dimethyluracil (37, R=H) by treatment 
with bromine (Bredereck, Herlinger, and Resemann, 1960). 
Subsequently a number of attempts were made to replace 
the bromo group by an amino group. Firstly, refluxing 
with aqueous ammonia (25 % NH 3 ) was tried but after 
completion of the reaction only the debrominated product, 
i.e. 6-benzylamino-1,3-dimethy l uraci l (37, R=H) was 
obtained. One previous observation (Paul and Sen, 1963) 
of debrominations of this type occurring under similar 
conditions has been made in the pyrimidine series. 
Wh·en ethanolic ammonia instead was employed under reflux 
conditions, 8-phenyltheophylline (14) was obtained. 
In this case displacemen t of the bromine atom by a 
nitrogen containing group must have occurred at some 
stage prior to ring-closure but lack of evidence does not 
allow any conclusion to be drawn as to the mechanistic 
I I 
j 
•• 
'I 
I 
I 
h 
pathway followed. As in the transamination 
experiments it seems more thar likely that 
intermediate 5- amino-6-benzylaminopyrimidine 
is formed and this r erivative undergoes an 
38. 
aerial oxidative cyclisation to the 8-phenylpurine, 
most probably by way of a benzylideneaminopyrimidine 
intermediate. 
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E. ATTEMPTED SYNTHESIS OF 7,9-DIBENZYLT HE OPHYLLINIUM 
BROMIDE 
In addition to 7,8- and 8,9-dibenzy l theo-
phylline a third dibenzyl derivative, the quaternary 
salt of 7,9-dibenzyltheophy lli ne (40) was possible. 
Such a derivative was of interest because, firstly, 
it was expected that owing to the charged nature of 
the imidazole ring one of the benzyl groups might be 
labile and undergo rearrange ment, which might include 
3 ? . 
an N + C-8 migration, and second l y, to observe the effect 
of the chemical shifts due to location of the benzylic 
groups on the nitrogen atoms of the shared quater nary 
system. Some 7,9-dialkyl quaternary derivatives of 
xanthines of this type have been prepared under forcing 
co nditions, using methyl p-toluenesulphonate at 170 0 
(Bredereck, 1962). An attempt to quaternise 7-benzyl-
theophylline (2) was made therefore with benzyl bromide 
in dimethylformamide under reflux conditions (160 0 /30h). 
The product obtained on working up was apparently unchanged 
starting material (2). The benzylation was then repeated 
but using the same conditions as were employed in the 
benzylation of theophylline (Section 1Ba) i.e. in aqueous 
sodium hydrogen carbonate under reflux. Again, the 
7-benzylpurine was recovered unchanged but t.l .c. examin-
ation of the concentrated mother liquor showed a spot 
corresponding to that of i,8-di benzyltheophylline. As 
! 
II 
H 
, II 
1/1 
~, 
I~ 
u 
:~ 
40. 
the amount present was not suffic i ent for isolation 
or characterisati on of this derivative the presence 
of the spot cannot be taken as ev id ence of the formation 
of the 7,8-dibenzyl homologue. 
In a fresh approach to forming the quaternary 
salt the benzylation of the 9-benzyl isomer (41) was 
considered; it was thought that in view of the fact th a: 
theophylline derivatives invariably underwent alkylation 
at N-7 it might be a more successful route. This 
purlne was prepared by the method of Blicke and Schaaf 
(1956) the last stage of wh i ch involves the desulphur-
isation of t he 9-benzy l -8-thiopurine (42) with nitrous 
acid using Biltz's (1921) procedure. 
On heating 9-benzyltheophyl lin e with benzyl 
bromide in dimethylformamide, under reflux, a different 
result was obtained from that above using the 7-benzyl 
lsomer. In this case the main product was not starting 
material but 7-benzyltheophy lli ne. The overal l effect 
of this reaction was a migration of the benzyl group from 
N-9 to N-7 (Scheme 13). A mechanism to exp lain th i s 
could well involve the initial formation of the required 
quaternary derivative (40) which subsequent l y loses the 
benzyl group at N-9. Reactions of this type are known, 
one example being when 7,9-d im ethylhypoxanthinium bromide 
(42) was heated in dimethylacetamide both 1,7- (43) and 
1,9-dibenzylhypoxanthine (44) were among the products 
40a. 
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isolated (Montgomery, 1966). For this reaction 
(Scheme 14) it was proposed that the displaced benzyl 
ion combines with the halogen ion to form the benzyl 
halide required for benzylation a t the new site 
(Neiman and Bergmann, 1968). In order to check if 
a similar reaction mechanism was responsible for the 
interconversion of 9- to 7-benzylthe ophylline the 
9-benzylpurine was converted to the hydrobromide salt. 
On heating the salt in dimethylformamide the only 
product was 7-benzyltheophylline (Scheme 13), as found 
41 . 
in the benzyl bromide treatment. In the residues some 
unchanged 9-benzyl isomer was detected on t.l.c. exam-
ination. Previous workers have demon st rated the 
necessity for the presence of halogen acids in benzyl 
group migrations of this kind and it was of interest to 
determine if these reagents were also necessary in this 
N-9 to N-7 group migration. A repeat heating of 
9-benzyltheophylline wa s therefore carried out ln 
dimethylformamide but in the absence of the hydrogen 
bromide. In this case on l y starting material was 
recovered. It would appear, therefore, that this benzyl 
group migration falls into the same general category as , 
those previously described by Miyaki (1966) which require 
the formation and participation of a benzyl halide in the 
intermolecular rearrangement. 
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A somewhat unexpected finding was that when 
9-benzyl-8-benzylthiotheophylline (45) was given the 
same heat treatment in dimethylformamide no migration 
of the 9-benzyl group was found to occur. Mainly 
starting material was recovered together with a small 
amount of the 8-thio analogue (42) which had been 
formed by ~-debenzylation. This observation may not 
42. 
be too unusual in view of reports that N-benzyl groups 
adjacent to thio groups are resistant to displacement by 
halogen acid treatment (Neiman and Bergmann, 1968). 
F. SYNTHESES AND STUDIES OF 7,8-DIMETHYL-2-METHYLTHIOPURINE 
It has been reported (Brown and Ford, 1969) that 
from the methylation of 2-methylthiopurine with diazo-
methane, in addition to the 9-methylated purine as the 
major product, a minor product, the analysis of which 
corresponded to that of a dimethylated 2-methylthiopurine, 
was obtained. On the basis of n.m.r., mass and u.v. 
spectral data this minor product was proposed to be 
7,8-dimethyl-2-methylthiopurine, although, at the same 
time, the possibility that it might be the 1,8-dimethyl-
2-methylthio isomer, was not completely ruled out. 
In this case diazomethane treatment had not 
only given the expected ~-methylated pr od uct but in 
addition a f-methylated derivative also. Although 
examples of C-methyl derivatives being formed following 
43. 
diazomethane treatment have been reported in a 
number of heterocycles (Review, Gompper, 1963) 
this appears to be the f i rst exa ~ol e of this kind 
to be found in the purine series. 
With the aim, therefore, of checking 
whether the structure of the minor prod uct was the 
one that had been proposed, the unambiguous syntheses 
of 7,8-dimethyl-2-methylthiopurine was attempted. 
The first step in the synthesis was the 
acylation of 4-amino-5-methylamino-2-methylthio-
pyrimidine (46) with acetic anhydride to obtain 
4-amino-5-(li- meth yl )acetamido-2-methylthiopyrimidine 
( 47) . Ring-closure of this derivative to the purine 
(48) required fairly vigorous conditions and was 
finally achieved by heating in dimethylformamide 
under reflux conditions. 
The physical data of 7,8-d i methyl-2-methyl-
thiopurine (48) were found not to be consistent with 
those reported for the minor product, the mo s t 
significant variation being shown between the two 
melting points, the figur es for the minor product 
(158-159 0 ) being some 40 0 below those of the synthesised 
purine (197-198 0 ). A comparison of the 1H n.m.r. data 
(Table 3) also shows that considerable differences exist 
in the chemical shifts of the corresponding groups. 
44. 
Table 3 
1H N.m.r. data (6 values) for ~-8-dimethyl-2-
methylthiopurine and re l ated derivatives (CDC1 3/TMS). 
6H SMe 8-Me NMe 
~,8-Me2-2-SMe 8.31 2.84 2.94 4.22 
7,8- Me 2-2-SMe 8.61 2.60 2.60 3.77 
8,9-Me 2-2-SMe 8.81 2.63 2 . 61 3.74 
1-Me-2-SMe 9.22 2.78 4.01 
Unfortunately, so far, no derivatives of 3-methyl-
2-methylthiopurine are available for 1H n.m.r. 
spectral examination and therefore the only data 
available for comparison with that from the 
~,8-dimethyl-2-methylthiopurine are those from the 
1-methyl-, 7-methyl- and 9-methyl-2-methylthiopurines. 
Only with the ultraviolet spectra is fairly close 
agreement obtained, the wavelength maxima of the 
diazomethane methylation product (311 nm and 242 nm) 
in aqueous solution at neutral pH comparing favourably 
with those found with 7,8-dimethyl-2-methylthiopurine 
(309 nm and 238 nm) under similar c ond itions. This 
particular spectral likeness is, however, not greatly 
significant as the ultraviolet spectra of a number of 
~- and I-methy l ated derivatives of methylthiopurines 
also show abso rp tion maxima around these wavelengths 
(Brown et ~., 1967). As some mass spectral results 
had also been given (Brown and Ford, 1969) for the 
minor methylation product a similar examination of 
the 7,8-dimethyl isomer was made. The fragmentation 
pattern of the latter (Figure 2) was different from 
45. 
that reported by Brown and Ford (1969). These workers 
only noted that first HeN and then an acetonitrile 
fragment was produced from their purine whereas in the 
case of the synthetic product a methylenethio fragment 
was initially removed, this then being followed by 
acetonitrile and subsequently by an HeN fragment. 
From the above comparisons it is seen that 
the minor methylation product is not the same as the 
7,8-dimethyl derivative (48). As the 8,9-dimethyl 
lsomer (49) has been already exc luded by its synthesis 
(Brown and Ford, 1969) the remaining possibilities are 
for either the 1,8-dimethyl (50) or 3,8-dimethyl-2-
methylthiopurine (51). Of these two latter derivatives 
the 3,8-dimethyl might be the more likely as this would 
be expected to show a lower 6-H chemical shift than 
shown by 1-methyl-2-methylthiopurine. The high value 
(9.22 0) shown by the latter is the highest of the 
purines studied (Table 3) and in part is due to the 
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47. 
quinonoid form as in the homologue (50), and the 
proximity of the ~-methyl group. In the case of 
the 3-methyl isomer (51) only a part quinonoid form 
is possible and the influence of the ~-methyl group 
not so direct. 
G. CONCLUDING REMARKS 
A survey of the results obtained from the 
alkylation and synthetic studies of the benzyltheo-
phylline derivatives allows some conclusions, of a 
general kind, to be drawn for the possible mode of 
formation of 7,8-dibenzyltheophylline during the 
alkylation of theophylline in alkaline solution. 
The most important aspect of this is an appreciation 
of the way in which the 8-benzylation step, i.e. the 
C-alkylation, occurs. 
Of all benzylation reactions carried out 
the only ones which have given significant amounts of 
8-benzylated theophyllines are those using conditions 
under which the formation of benzyl radicals is favoured. 
This view is supported also by the fact that under these 
conditions the yield of the norma l alkylation product, 
7-benzyltheophylline is much reduced, this is ln 
agreement with the known tendency of radicals to prefer 
attack at a carbon rather than a nitrogen atom. 
Further indirect support for the radical theory lS 
glven by the results from the quaternisation 
attempts on 7- and 9-benzyltheophylline. In 
these no indications of the formation of any 
of the 7,8-dibenzyl homologue is found even though 
highly reactive benzyl carbocations are presumed 
to be generated during the rearrangements studied. 
Assuming, therefore, that radical 
involvement leads to the formation of 8-benzyl-
theophylline a possible complicating factor has 
to be recognised when considering the next step. 
In the conversion of the 8-benzyl derivative to the 
7,8-dibenzyl homologue steric hindrance is found to 
obstruct the entry of the second benzyl group at N-7. 
This is shown by the forcing conditions (i .e. alkyl-
ation in dimethylformamide containing potassium 
carbonate under reflux) needed to carry out the 
reaction. Possibly this factor is also the reason 
for the failure to isomerise the 8,8-dibenzylpurine 
to the 7,8-dibenzyl form. As radicals as well as 
ions are affected by steric considerations this could 
also explain why ultraviolet irradiation of 7-benzyl-
theophylline, in the presence of benzyl bromide, did 
not give any 7,8-dibenzyltheophylline. 
48. 
To sum up, from the available evidence 
it would appear that the most likely pathway to 
7,8-dibenzyltheophylline, which arises fro m 
benzylation of theophylline, is by an initial 
attack by radicals occurring at C-8, the benzyl 
radicals being generated by thermolysis of the 
benzyl halide. Some of the 8-benzyltheophylline 
so produced then undergoes an ionic alkylation at 
N-7 to give the dibenzyl derivative. This latter 
step seems to be time and temperature dependent, 
as fairly rigorous conditions were required to 
overcome the steric barrier of the 8-benzyl group. 
The alternative mechanism, in which formation of 
the 8-benzylth eophilline occurs by an N7(or N9 )-
benzyl group migration to C-8, would appear to be 
ruled out on the practical evidence reported above. 
49. 
PART II. The 2-Cyc10a1ky1amino-6,9-dimethy1purines 
A. INTRODUCTION 
Historical 
Ph1eomycin is a copper-containing protein which 
has antibiotic and antitumour activity (Bradner and 
Pindell, 1962; Tanaka, et a1., 1966; Ishizuka, et ~., 
1966). This antibiotic, when introduced into cultures 
of stationary-phase E.co1i B cells at doses of <2 ~g/m1, 
induces neither DNA breakdown nor cell death, but on 
the addition of 8mM caffeine these kinds of changes are 
initiated. As the same effect can be produced by 
increasing the ph1eomycin concentration tenfold the 
phenomenon is termed lIamp1ificationli. 
50 
In the light of the results derived from the 
caffeine studies a wide range of purines has been 
synthesised (Grigg, 1971; Brown, 1972; Grigg, 1972; 
Badger, 1974; Angyal, 1974) and tested. Although no 
preClse structure-activity relationships emerged from 
this work amplification effects were generally most 
pronounced with some 2-a1ky1thiopurines and corresponding 
2-dimethylaminopurines. Furthermore, it was also 
apparent that an alkyl group at C-6 or C-8 or on an 
imidazole nitrogen atom, or a combination of these, 
was beneficial for biological action. 
Present Work 
In an attempt to improve on the activity of 
the 2-dialkylaminopurines, some 6,9-dimethylpurines 
with cycloalkylamino groups at the 2-position were 
synthesised and tested for their amplifying effect. 
For the preparation of these purines Traube's synthesis 
was employed, this involved the introduction of one 
carbon fragment to bridge the nitrogen atoms of t he 
amino groups at C4 and C5 of the pyrimidine ring 
(Scheme 15). Use of this route enabled the 2-cyclo-
alkylamino moiety to be inserted prior to ring closure 
of the pyrimidine to the purine. 
B. SYNTHETIC STUDIES 
The 2-dimethylamino group in the biologically 
active 6,9-dimethylpurine (52) was replaced by a series 
of cyclic analogues, using polymethylene amines with 
rings containing from four up to seven carbon atoms. 
In this way, while the basic function of the group at 
51 
the 2-position was not greatly changed, by the replace-
ment of the dimethyl amino group, there was, however, a 
great difference in the steric requirements of the purine. 
It was felt that the variation of this property with ring 
size might give some indication of the mode of biological 
action in the potentiation of phleomycin. 
The key intermediate for the preparation of 
the 2-cycloalkylaminopurines (53, n=2,3,4 and 5) 
1'0 
r
-f 
>
-
LD
 
:::c 
+
 
X
 N
 
:::c 
+
 
0::: 
A
 
U
') 
<lJ 
<lJ 
s:: 
Z 
Z
L 
.,..... 
s.... 
::J 
0... 
<lJ 
4
-
L 
Z 
0 
~J 
U
') 
~I 
.,..... 
Z 
U
') 
<lJ 
t / \ 
<lJ 
E 
.c
 
<lJ 
+-> 
.c
 
s:: 
u
 
>
, 
(/) 
U
') 
0::: 
I 
<lJ 
.
.c::l 
U 
::J 
//\ 
1'0 
s.... 
X
 
>
-
r-
+
 
<lJ 
N
 
~
 
:::c 
:::c 
Z 
Z 
~() Z /\ 
( 52) 
(54) 
N 
Nl 
Me 
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(
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CH ) 2U ~N )NHM e 
( 55) 
5Ib 
2-chloro-4-methyl-6-methylamino-5-nitropyrimidine 
(54) was prepared according to the method in the 
literature (Brown, England and Lyall, 1966), 
starting from 6-methyluracil, which is then 
successively nitrated, chlorinated and then 
selectively aminated at the 6-position. On 
treatment of the 2-chloropyrimidine (54) with a cold 
ethanolic solution of the appropriate cyclic amine 
the required polymethyleneaminopyrimidines (55, n=4-7) 
were obtained. These nitropyrimidines were readily 
reduced by catalytic hydrogenation over Raney nicke 
in methanol at room temperature and the resulting 
aminopyrimidines were cyclised directly to the 
appropriate purines, using Traube's method, by 
refluxing with formic acid (98%) for a few hours. 
An exception was the case of 5-amino-4-methyl-6-
methylamino-2-(octahydroazocin-1-yl )pyrimidine 
(56, R=H, n=7) which gave the crude formyl derivative 
(56, R=CHO, n=7); this was converted to the required 
purine by heating it under reflux in formamide. 
C. BIOLOGICAL RESULTS 
Due to problems of solubility complete data 
52 
are not available of the in vitro testing of the various 
2-polymethyleneaminopurines (53) as potentiators of 
phleomycin. The results obtained so far (Table 4) 
53 
show a reasonably high activity for the 2-piperidinyl 
derivative (53, R=H, n=3); the activity value of 235 
(at 2mM concentration) can be compared with that of 11 
(at 2mM) for caffeine the standard purine employed in 
these tests. It is interesting to note that if the 
8-position of the above purine is blocked by insertion 
of a methyl group, as a means of preventing normal 
metabolic hydroxylation occu rr ing at this position, 
then the activity figure for the resulting 6,8,9-trimethyl 
analogue (53, R=Me, n=3) is reduced to 90 (at 2mM) l.~. 
to a value 40% of the original figure (Bhushan et ~., 
1975). The decrease in solubility of the purine, due 
to the extra methyl group, may, however, be as an 
important a factor in the lowered biological activity 
as the effect of blocking the metabo l i c oxidation step. 
A noteworthy point in connection with this is that 
unpublished results from the ongoing programme show 
that conversion of an 8-methylpurine to the 8-hydroxy-
methyl analogue occurs in the metabolic pathway of some 
of the related 2-alkylthiopurines tested. This suggests 
that the sought after antimetabolic effect may not be 
achieved simply by introduction of the methyl group at 
the unsubstituted position. Although the piperidino 
and morpholino groups have approximately the same size 
and configuration replacement of the former by t he other 
leads to a significant reduction in activity ( 40/2mM) 
in both di- and tri-methylpurines. 
When the 2-piperidinopurines are compared 
with the 2-dimethylamino analogues (52, R=H and Me) 
activities of the same magnitude are found but the 
order for the dimethyl and trimethyl derivatives 
1S completely reversed. 
These results demonstrate, therefore, the 
difficulty in proposing a rationale for the 
potentiating activity of the 2-alkylamino derivatives. 
The presence of a similarly shaped group is shown, 
by the significantly different results from the 
piperidino and morpholino analogues, not to be 
essential. Likewise, the contrast between the 
piperidino and dimethylamino values indicates that 
even though the two parent amines have similar pKa 's 
(piperidine 11.2, dimethylamine 10.9) basicity alone 
is not a major factor in the activity criteria. 
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Table 4 
Potentiating effect of 2-Alkylamino-6,9-dimethyl- and 
6,8,9-trimethylpurines on the activity of Phleomycin 
in vitr o towards E. co Zi 
Me 
N~ Rl 
N 
R Rl 
piperidino ~ H 
piperidino ~ Me 
dimethylamino ~ H 
dimethylamino ~ Me 
morpholino H 
morpholino a Me 
N>Rl 
N 
Me 
Activity, 
233, 
9 ° , 
85, 
225, 
concentration* 
2mM 
2mM 
8mr~ 
8mM 
40, 2mM 
40, 2m M 
(Note*. Caffeine, as standard, activity 30, 8mM and 
a Bhushan (1975). 
b Brown (1972). 
11, 2mM) 
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PART III The 8-Alkoxy-6-amino purines 
A. INTRODUCTION 
It was only some two years ago that the use 
of tetraethoxymethane (tetraethyl orthocarbonate) (57) 
was pioneered as a cyclising agent in the synthesis of 
heterocycles. In the earliest examples 5-amino-4-
56 
formyl-1,2,3-triazole was converted into the correspon-
ding 5-diethoxymethyleneamino derivative (58) this upon 
subsequent treatment with amines then undergoing cyclis-
ation to give 5-ethoxy-~-triazolo-[4,5-9]pyrimidines (59) 
(Albert and Taguchi, 1973). In other studies 5-amino-4-
hydrazinopyrimidines were similarly converted initially 
into their 4-diethoxymethylenehydrazino analogues (60) 
prior to their cyclisation and subsequent oxidation to 
3-ethoxypyrimido[5,4-~]-as-triazines (61) (Brown and 
Lynn, 1973). 
Orthoesters, which are the trialkoxymethane 
analogues of the orthocarbonates, have been extensively 
used to cyclise 4,5-diaminopyrimidines to the correspon-
ding 8-unsubstituted or 8-alkylpurines depending upon 
the orthoester employed. For example, purines having 
a methyl or ethyl substituent at C-8 have been prepared 
from triethyl orthoacetate and triethyl orthopropionate, 
respectively (Koppel and Robins, 1958; Prasad, Noell, 
and Robins, 1959: Montgomery and Temple, 1960; 
Pfleiderer, 1961). 
EtO\ (N~ 
C= N "N 
EtO/OHC I / 
N 
H 
(58) 
NH2 OEt 
" NH.N=C 
'OEt 
( 60) 
OEt 
I 
EtO-C-OEt 
I 
OEt 
( 57) 
N 
RNH2 RN .- ~ ~ 
~ Eto l A /N 
N N 
H 
(59) 
Oxidation ~ 
R 
~ N 
Rl~N 
N ~ OEt 
~N 
N 
( 61) 
56a 
I 
It 
,I 
.! 
A notable feature of orthoester cyclisations 
ln purine synthesis is that when employed with 
4,5-diamin~-6-monosubstituted-aminopyrimidines, the 
major, and in most cases, only product is the 
6-substituted-aminopurine. This is contrary to the 
situation found with most other cyclising agents which 
give the isomeric 9-substituted adenine as the main 
product of the ring-closure (Scheme 16). 
It was only recently (Brown and Lynn, 1974) 
that the analogous use of tetra-alkyl orthocarbonates 
57 
was attempted for the conversion of 4,5-diaminopyrimidines 
into 8-alkoxypurines. In view of the difficulties which 
have been encountered previously in the syntheses of 
8-alkoxypurines, the advantage of this reagent for 
allowing the direct introduction of an alkoxy group at 
the 8-position is apparent. Prior to this no generally 
applicable or conven i ent methods existed, the most usual 
route to 8-alkoxy derivatives was by the displacement by 
an alkoxy group of a suitable 8-substituent, this being 
either a halogen (Robins, 1958), methylthio or methyl-
sulphonyl group (Brown and Mason, 195 7 ), in an existing 
purine. This procedure in most cases required fairly 
drastic conditions in view of the usually low reactivity 
of a group at the 8-position towards nucleophilic displa-
cement. Of even less general appl icabil ity was the 
method of O-alkylation of 8-oxopurines, this pr oc edure 
does not appear to be effective except with certain 
derivatives of uric acid. 
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Present Work 
Arising from the initial encouraging results 
which had been obtained with this class of reagent in 
8-alkoxypurines syntheses by Brown and Lynn (1974) 
further studies have been undertaken to explore further 
the versatility of orthocarbonates for this purpose. 
One aspect given particular attention was to ascertain 
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if these reagents behaved towards 4,5-diamino-6-
substituted-aminopyrimidines like the related orthoesters, 
in giving 6-substituted-aminopurines, rather than as with 
the majority of cyclising reagents, which give rise to 
the corresponding 9-substituted adenine isomers. 
B. SYNTHETIC STUDIES 
For the purpose of investigating the type of 
ring-closure that occurred with 4,5-diamino-6-substituted-
aminopyrimidines, i.e. whether ring-closure took place 
between the 4- and 5-primary amino groups or between 
the 5-amino and 6-substituted (secondary) amino groups; 
three triaminopyrimidines were prepared each one having 
a different size secondary amino group. These were the 
4,5-diamino-6-benzylaminopyrimidine (62, R=CH20) together 
with the 6-methylamino (62, R=Me) and 6-anilino (62, R=0) 
analogues. 
The key intermediate for the preparation of these 
triaminopyrimidines, 4,6-dichloro-5-nitropyrimidine, was 
obtained using the method reported in the literature 
(Boon, Jones and Ramage, 1951). 
Two possible routes were considered for the 
preparation of the required triaminopyrimidines 
(Scheme 17); : in the first route one of the halogen atoms 
is initially replaced by an amino group, using ammonia 
solution (route A), whereas in the other approach the 
secondary amino group is inserted first (route B). 
The intermediate 6-amino-4-chloro-5-nitro-
pyrimidine (route A) was found to be quite difficult to 
obtain in good yield by the method of Boon ~~. (1951) 
because of the formation of substantial amoun t s of 
4,6-diamino-5-nitropyrimidine which occurred through 
concomittant ammonolysis of both halogen atoms. 
It had been reported in the literature (Segal 
and Shapiro, 1959) that the chance of bis-ammonolysis 
occurring in the preparation of 4-amino-6-chloro-5-
nitropyrimidine was reduced to a minimum if the reaction 
was carried out in tetrahydrofuran in the presence of 
sodium bicarbonate. This procedure when used gave the 
required monoamino compound which was then treated with 
the required alkylamine, following the published 
procedure (Daly and Christensen, 1956), to give the 
desired 4-alkylamino-6-amino-5-nitropyrimidines. These 
5-nitro derivatives were then easily reduced by hydro-
genation over Raney nickel to the corresponding 
4-alkylamino-5,6-diaminopyrimidines. 
The alternative route (B) differs from the 
previous one in that the 4,6-dichloropyrimidi ne is 
treated first with the required alkylamine and the 
59. 
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halogen then is replaced with ammonla. However, when 
an attempt was made to treat 4,6-dichloro-5-nitro-
pyrimidine ~ith aniline, 4,6-dianilino-5-nitropyrimidine 
was obtained instead of the required 4-anilino-6-chloro-
5-nitropyrimidine. This route, however, did work in 
the case of methylamine and gave 4-chloro-6-methylamino-
5-nitropyrimidine. In view of the above findings the 
anilino- and benzylamino-pyrimidine derivat i ves were 
prepared by route A and the methylam i nopyrimidine 
derivative by route B. 
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All the triaminopyrimidines were condensed with 
the appropriate tetra-alkyl orthocarbonates by heating 
under reflux with an excess of the reagent for a prolonged 
period of time. The cyclisation, as has been stated 
previously, can occur in two ways (Scheme 18) to give 
either a 9-alkyladenine derivative (63) or a 6-alkyl-
aminopurine derivative (64) or a mixture of both. This 
point was investigated by treating the crude product 
obtained on completion of reaction with N-sodium hydroxide, 
to dissolve any of the 6-alkylamino analogue formed, and 
then to reprecipitate this purine by acidification of 
the alkaline extract. 
In practice it was found that with the 
benzylamino- (62, R=CH20) and anilino-pyrimidines (62, R=0) 
only the latter reacted successfully giving the 
9-phenyladenine derivative (63, R=0). In the case of 
4,5-diamino-6-benzylaminopyrimidine the intermediate 
5-diethoxymethylenea mino derivative (65) was isolated. 
Attempts to cyclise this by fusion in a metal bath did 
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not give 9-benzyl-8-ethoxyadenine (66), only starting 
material being recovered. With the methylamino-
pyrimidine~(62, R=Me) two products, separable by 
alkali treatment, were obtained. Analytical data 
showed the alkali insoluble derivative to be the 
8-ethoxy-9-methyladenine (63, R=Me), this being confirmed 
by 1H n.m.r. data. The analysis of the material 
recovered on acidification of the alkaline solution 
approximated to that for the monohydrated form of 
8-ethoxy-6-methylaminopurine (64, R=Me). No confirm-
atory evidence could be obtained from the n.m.r. spectrum. 
A notable feature of all the condensation products was 
that no satisfactory nitrogen analysis could be 
obtained for any derivative. 
On the basis of the results obtained so far, 
it would appear that the tetra-alkyl orthocarbonates 
do not resemble the orthoesters in their condensation 
reactions with 4,5-diamino-6-substituted-aminopyrimidines. 
They do not give 6-alkylaminopurines as the major product 
but behave like the majority of cyclising agents used in 
purlne syntheses and afford 9-alkyladenine derivatives 
as the sole or main products. This finding is quite 
interesting as the tendency to form the 6-substituted-
aminopurines would be expected to be quite large in view 
of the steric factors operating, as for example, in the 
case of the anilino-pyrimidine (62, R=0). 
62 
Attempts to ring-close the above 
triaminopyrimidines using either the tetramethoxy 
\ 
or tetrapropoxy orthocarbonates were unsuccessful. 
No identifiable products could be isolated from 
these reactions. 
PART IV. Experimental 
M i c r 0 a n\a 1 y s e s w ere car r i e d 0 u t by the Au s t r ali a n 
National University Analytical Services Unit. Solids 
for analysis were dried at 100 0 unless otherwise 
63 
stated. Melting poin t s were taken in Pyrex capill a ries 
and are corrected. 
All compounds were examined for the presence of 
impurities or isomers by thin layer chromatography 
(silica or alumina plates). Where possible, solids 
were recrystallised to constant melting points. 
IH N.m.r. spectra were measured at 60 MHz and 
35 0 with a Varian T-60A spectrometer and were 
determined in (C03)2S0 or COC1 3 , with tetramethylsilane 
as internal standard. Mass spectra were measured on 
an A.E.I. MS 9 instrument. 
Infrared spectra were measured as Nujol mulls on 
a Unicam SP 200 or SP 1000 instrument. Ultraviolet 
spectra were recorded with a Unicam SP 800 or SP 1800 
instrument. The ultraviolet source in the irradiation 
experiments was a 128W Oliphant chamber reactor equipped 
with interchangeable short (254 nm) or long (365 nm) 
wavelength lamps. 
All new compounds are underlined at their first 
mention in the body of the text of this Experimental 
Section. 
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A. BENZYLTHEOPHYLLINES AND INTERMEDIATES 
Benzylation of Theophylline. --To a solution of 
theophylline (5 g) and sodium hydrogen carbonate (2.3 g) 
in water (100 ml) was added benzyl bromide (4.7 g) and 
the mixture heated under reflux for 4 h. The 
crystalline product, which separated on cooling, was 
stirred with N sodium hydroxide solution, filtered and 
recrystallised from ethanol giving 7-benzyltheophylline, 
m.p. 156-157 0 (Traube, 1923: 158 0 ). Acidification of 
the alkaline filtrate (pH 5) with acetic acid gave a 
precipitate of 8-benzyltheophylline (0.07 g) m.p.289-2900 
(Hager et ~., 1954: 289-290 0 ). The ethanolic mother 
liquors from r ecrystallisation of the 7-benzyl derivative 
were evaporated and the residue taken up in chloroform 
and applied to a preparative t.l.c. plate (Merck type 60 
silica) and run in ethyl acetate. Extraction of the lower 
of the two main bands with hot chloroform gave more of the 
7-benzyl isomer (total yield 2.30 g) while from the upper 
band 7,8-dibenzyltheophylline (0.04 g), m.p. 120-121 0 was 
recovered (Found: C, 70.3; H, 5.7; N, 15.9. 
C21H20N402 requires C, 70.0; H, 5.5; N, 15.5 %). 
Evaporation of the aqueous filtrate from the original 
reaction mixture gave only unreacted theophylline (0.67 g). 
Virtually identical yields of the 7-, 8- and 7,8-benzylated 
derivatives, to those given above, were formed when the 
\ 
sodium salt of theophylline and benzyl bromide were 
reacted in water at 100 0 . In additi on to m.p.s further 
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confirmation of 7- and 8-benzyltheophylline was obtained 
from their spectral comparisons (i.r., 1H n.m.r.) with 
those of authentic specimens. 
~ 
8-Benzyltheophylline.--The solid, obtained on 
heating a mixture of 5,6-diamino-1,3-dimethylpyrimidine-
2,4-dione (5 g, 1 mole) and phenylacetic acid (5 g, 
1.25 mole) at 170-180 0 , was cyclised in sodium hydroxide 
solution (9 %), as described by Hager et al. (1954), to 
the required 8-benzyltheophylline (3.3 g) m.p.290-292° 
(Hager ~~., 1954: 289 0 ). 
Benzylation of Theophylline in the presence of 
Ultraviolet light.--To a solution of theophylline (5 g) 
and sodium hydrogen carbonate (2.3 g) in water (100 ml) 
was added benzyl bromide (4.7 g) and the mixture was 
heated for 12 h in the presence of ultraviolet light by 
means of superheated steam passing through the coils 
dipped in the reaction mixture; the maximum temperature 
of the solution attained was 92 0. The solid which 
separated out on cooling was filtered off and treated with 
cold chloroform and the chloroform extracts concentrated 
after drying over anhydrous sodium sulphate. The 
8-benzyltheophylline which separated out was removed 
and the chloroform mother liquors run on a silica t.l.c. 
plate. When the topmost band was extracted with chloroform 
7,8-dibenzyltheophylline (1.50 mg) m.p. 120-121 0 was 
obtained on evaporation of the extracts. 
The aqueous filtrate on standing threw out a solid 
which was found to be a mixture of 7-benzyl- and 
8-benzyltheQphylline. The former purine remained on 
treatment of the mixture with alkali from which 
8-benzyltheophylline was recovered on acidification 
of the solution. Further working up of the aqueous 
filtrate gave only theophylline. Respective yields 
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were 7-benzyltheophylline (0.40 g), 8-benzyltheophylline 
(0.14 g) and theophylline (2.30 g). 
When the experiment was repeated at 74 0 for 12 h, 
no 7,8-dibenzyltheophylline could be detected, 7-benzyl-
theophylline (0.6 g), 8-benzyltheophylline (0.5 g) and 
unreacted theophylline (2.55 g) only were recovered. 
Action of Crotyl bromide on Theophylline.--Sodium 
theophyllinate (1 g) in water (50 ml) was stirred with 
crotyl bromide (0.66 g) for 6 h. Crystallisation of 
the precipitate from methanol gave 8-crotyltheophylline 
(0.5 g) m.p. 232-234 0 ; n.m.r. S(DMSO) 1.60 (m, C-Me), 
3.20, 3.38 (s, N-Me), 3.38 (s, CH 2), 5.56 (m, CH=CH). 
Evaporation of the aqueous filtrate from the reaction 
mixture gave only unreacted theophylline (0.12 g) while 
the methanolic mother liquors from the crystallisation 
were found to contain only minor amounts of 8-crotyl-
theophylline. All the precipitated 8-crotylpurine was 
alkali soluble, !.~. no 7-alkylated isomer was present. 
This was confirmed by t.l .c. examination of the products. 
Benzylation of 8-Benzyltheophylline.--The sodium 
salt of 8-benzyltheophylline, prepared by evaporating 
to dryness a solution of the purine (1 g) in N sodium 
~ 
hydroxide (9 ml) and water (25 ml), was heated (oil 
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bath) with benzyl chloride (0.8 ml) in dimethylformamide 
(25 ml) under reflux for 4 h. After removal of the 
solvent the residue was crystallised from ethanol to . 
give 7,8-dibenzyltheophylline (0.7 g), identical 
(m.p., i.r., n.m.r.) with that previously described. 
When the benzylation experiment in aqueous solution 
was attempted in the absence of sodium hydroxide, only 
starting material was recovered. 
6-Amino-5-benzylamino-1,3-dimethylpyrimidine-2,4-
dione.--5,6-Diamino-1,3-dimethylpyrimidine-2,4-dione 
(5 g) and benzaldehyde (3.5 g) were stirred in ethanol 
(100 ml) at room temperature for 2 h, using the procedure 
of Traube and Nithack (1906). The 6-amino-5-benzylidene-
amino-1,3-dimethylpyrimidine-2,4-dione (4.5 g) which 
separated out had a m.p. 218-219 0 . 
A solution of 6-amino-5-benzylideneamino-1,3-
dimethylpyrimidine-2,4-dione (5 g) in ethanol (150 ml) 
was hydrogenated over Raney nickel until hydrogen uptake 
was completed. After removal of the catalyst and 
evaporatio n of the solvent the residue was crystallised 
from ethanol giving 6-amino-5-benzylamino-1,3-dimethyl-
pyrimidine-2,4-dione (3.5 g) m.p. 184-186 0 (Found: C, 60.2; 
H, 5.8; N, 21.8. C13H16N402 requires C, 60.0; H, 6.2; 
N,21.5 %). 
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Following Sugimoto and Matsuura's method (1968) 
a mixture of 5,6-diamino-1,3-dimethylpyrimidine-2,4-
dione (5 g) ~ and benzaldehyde (3.4 g) in ethanol (150 ml) 
when hydrogenated under the foregoing conditions also 
gave the same 6-amino-5-benzylaminopyrimidine (m.p., 
i.r., n.m.r.). 
Conversion of 6-Amino-5-benzylamino-1,3-dimethyl-
pyrimidine-2,4-dione into 7-Benzyltheophylline.--After 
heating a solution of the above 5-benzylamino derivative 
(0.2 g) in formic acid (98 %, 15 ml) under reflux for 4 h 
and then evaporating to dryness only the 
5-(~-benzyl )formamidopyrimidine was obtained. This 
crude product was taken up in formamide (5 ml) containing 
hydrochloric acid (0.1 ml) and heated at 170 0 (oil bath) 
for 1 h then taken down in vacuo to dryness. On 
crystallisation of the residue from ethanol 7-benzyl-
theophylline (0.1 g) was obtained, identical (m.p., i.r.) 
with that derived from benzylation of theophylline, 
described above. 
Attempted preparation of 7,8-Dibenzyltheophylline.--
(a) With phenylacetic acid: 6-Amino-5-benzylamino-1,3-
dimethylpyrimidine-2,4-dione (0.1 g) and phenylacetic 
acid (0.06 g) were fused at a temperature of 200 0 on a 
metal bath for 2 h. After cooling, the crude product 
was crystallised from ethanol and identified by l.r., 
n.m.r. and m.p. (288 0 ) as 8-benzyltheophylline. 
(b) With phenyl acetamide: 6-Amino-5-benzylamino-
1,3-dimethylpyrimidine-2,4-dione (0.1 g) and 
phenylacet~mide (0.07 g) were fused at 250-260 0 for 
3 h, cooled and the solid melt recrystallised from 
ethanol. The i.r. and m.p. (287-289 0 ) confirmed it 
to be 8-benzyltheophylline. 
(c) With benzyl cyanide: When 6-amino-5-benzylamino- . 
1,3-dimethylpyrimidine-2,4-dione (0.1 g) and benzyl 
cyanide (10 ml) were heated at 270 0 for 4 h, then 
cooled, a yellow solid emerged, identified by i.r. 
and n.m.r. as 8-phenyltheophylline. 
6-Amino-5-benzylaminopyrimidine-2,4-dione.--
Following Traube's (1923) method 5,6-diaminopyrimidine-
2,4-dione (5 g) was dissolved in hot water (250 ml) and 
benzaldehyde (2 g) then added with stirring. When the 
addition was completed the solution was brought to pH 7 
with IN sodium hydroxide and stirred for 4-5 h. The 
precipitated 6-amino-5-benzylideneaminopyrimidine-2,4-
dione (3.5 g) was purified by reprecipitation from 
alkali with acetic acid, m.p. 330 0 (dec.). 
6-Amino-5-benzylideneaminopyrimidine-2,4-dione (2 g) 
was suspended in water (70 ml) and 5% sodium amalgam 
(60 g) was added (Traube, 1923). The contents of the 
flask were shaken for 5 h and the solution decanted 
from the mercury residue. On neutralisation of the 
aqueous layer with acetic acid 6-amino-5-benzylamino-
pyrimidine-2,4-dione (1.1 g) precipitated out. 
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Further purification by reprecipitating from 
alkaline solution gave a product with m.p. 264-266 0 
(Found: C, 56.6; H, 5.2; 
for CIIHI2N402: C, 56.9; 
N, 24.4. Calculated 
H, 5.2; N, 24.1 %). 
6-Amino-5-(N-benzyl )phenylacetamidouracil.--
Under fusion conditions (230 0 , 4 h) 6-amino-5-benzyl-
aminopyrimidine-2,4-dione (1 g) and phenylacetic 
acid (0.72 g) gave the 5-(N-benzyl )phenylacetamido 
derivative (0.6 g), m.p. >300 0 , obtained pure by 
reprecipitation from alkali with acetic acid 
(Found: C, 65.1; H, 5.0; N, 15.5. C19H1SN403 
requires: C, 65.1; H, 5.1; N, 16.0%). 
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7,S-Dibenzylxanthine. --Heating a solution of the 
foregoing 5-(~-benzyl )phenylacetamido derivative (1 g) 
in 2N sodium hydroxide for S h, followed by neutraliz-
ation with acetic acid (pH 6) gave 7,S-dibenzylxanthine 
(0.5 g) m.p. 270 0 (dec. )(Found: C, 66.9; H, 4.9; 
N, 16.2. C19HI6N402.0.5H20 requires: C, 66.9; 
H, 5.0; N, 16.4 %). 
Attempted methylation of 7,S-dibenzylxanthine. --
When the methylation of 7,S-dibenzylxanthine in 
sodium hydroxide with methyl iodide was attempted 
at room temperature only the starting material was 
recovered. Complete solution of the xanthine deriv-
ative in the alkaline medium could not be obtained. 
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Attempted Condensation of 5,6-Diamino-1,3-
dimethylpyrimidine-2,4-dione with the bisulphite adduct 
of Dibenzyl ~ Ketone.--A saturated solution of sodium 
bisulphite in water and dibenzyl ketone in ethanol were 
mixed and shaken for a short time, the crystalline 
bisulphite adduct of dibenzyl ketone separating out. 
5,6-Diamino-1,3-dimethylpyrimidine-2,4-dione (0.1 g) 
and the bisulphite adduct (0.23 g) were refluxed ln 
ethanol (15 ml) for 2 h, then filtered. The 8-benzyl-
theophylline, which separated out on chilling the 
filtrate, had a m.p. 288-290 0 and gave an infrared 
spectrum superimposable with that of the authentic 
specimen. 
This condensation, when a tt empted in n-butanol and 
methanol, also gave 8-benzyltheophylline as product. 
Attempted Condensation of 5,6-Diamino-1,3-
dimethylpyrimidine-2,4-dione with bisulphite adduct of 
Benzylmethyl ketone.--The bisulphite adduct of benzyl-
methyl ketone was prepared in a similar manner to that 
described for dibenzyl ketone: 5,6-diamino-1,3-dimethyl-
pyrimidine-2,4-dione (0.23 mole) and the bisulphite 
adduct of benzylmethyl ketone (0.28 mole) were refluxed 
in n-butanol for 6 h. After removal of the solvent the 
residue was recrystallised from ethanol giving 8-methyl-
theophylline, having the same m.p., i.r. and n.m.r. as 
an authentic specimen. 
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Synthesis of 8-Methyltheophylline. --5,6-Diamino-
1,3-dimethylpyrimidine-2,4-dione was heated under reflux 
with acetic ~anhydride containing a catalytic amount of 
pyridine (0.1 ml), as described by Bredereck et ~. 
(1953), giving 8-methyltheophylline, m.p. 330-332 0 . 
Condensation of 6-Amino-1,3-dimethyl-5-nitroso-
pyrimidine-2,4-dione with bisulphite adduct of dibenzyl 
ketone. --6-Amino-1,3-dimethyl-5-nitrosopyrimidine-2,4-
dione (1 mole) and the bisulphite adduct of dibenzyl 
ketone (1.1 mole) were heated under reflux in dimethyl-
formamide for 2 h. At the end of this period the 
contents of the flask were evaporated to dryness and 
the residue recrystallised from ethanol giving 
8-benzyltheophylline with the same m.p., i.r. as an 
authentic sample. 
4-Hydroxy-1,3-dimethyluracil .--This was prepared 
by following the method of Pfleiderer et ~. (1958). 
N,N'-Dimethylurea (88 g), malonic acid (120 g) and 
acetic acid (190 ml) were heated with stirring at 60-70 0 
till solution was obtained. Acetic anhydride (400 ml) 
was then added and the temperature raised slowly to 90 0 
and kept there for 6 h. After leaving overnight the 
mixture was evaporated to a syrup and to this warm 
ethanol (100 ml) was added. The resulting crystalline 
product was filtered off, washed with ethanol, and 
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heated with hydrochloric acid (120 ml) and water 
(150 ml) under reflux for 2 h. On cooling long 
needles of the 4-hydroxyuracil, m.p. 120-121 0 
(Pfleidere~, 1958: 123-124 0 ) separated out. 
6-Chl oro-1 ,3-dimethyl uracil.-4-Hydroxy-1 ,3-
dimethyluracil(50 g) was treated with water (16 ml) 
and then phosphorus oxychloride was added slowly 
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(400 ml). When the addition was complete the mixture 
was heated under reflux (40 min) on an oil bath. After 
removal of the excess of phosphoryl chloride the syrup 
was poured onto ice with stirring. The resulting 
solution was filtered and the filtrate extracted with 
chloroform (5 x 100 ml), the combined extracts dried 
over sodium sulphate and evaporated to dryness. The 
required chlorouracil, m.p. 110-111 0 was obtained on 
crystallisation of the residue from water. 
2-Amino-1,3-diphenylpropane.-Dibenzyl ketone 
(5 g) was mixed with an equivalent of hydroxylamine 
hydrochloride in ethanol (15 ml) containing a drop 
of hydrochloric acid. The ketoxime was obtained as 
a crystalline solid, m.p. 120-121 0 (Francis, 1899: 
119-125 0 ) on heating the mixture under reflux (1.5 h) 
and then cooling. 
The ketoxime was reduced by hydrogenation over 
Raney nickel in ethanol to give 2-amino-1,3-diphenyl-
propane. This was purified by conversion to the 
hydrochloride, m.p. 205 0 , yield 2.8 g. 
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6-(I-Benzyl-2-phenyl )ethylamino-l,3-dimethyl-
pyrimidine-2,4-dione.--2-Amino-l,3-diphenylpropane 
(2 g, 1 mole) was mixed with 4-chloro-l,3-dimethyl-
~ 
uracil (1.7 g) and heated in dimethylformamide (15 ml) 
74 
for 1.5 h. On chilling the reaction mixture 6-(I-benzyl-
2-phenyl)ethylamino-l,3-dimethylpyrimidine-2,4-dione 
separated out, m.p. 272-273 0 , yield 0.8 g (Found: 
C, 72.3; H, 6.4; N, 12.2. C21H23N302 requires: 
C, 72.2; H, 6.6; N, 12.0%). 
Attempted C-nitrosation of 6-(I-benzyl-2-phenyl) 
ethylamino-l,3-dimethylpyrimidine-2,4-dione.--Following 
the method of Goldner ~~. (1966) 6-(I-benzyl-2-
phenyl)ethylamino-l,3-dimethylpyrimidine-2,4-dione 
(0.05 g) was treated with isoamyl nitrite (0.15 ml) and 
ethanolic hydrogen chloride and left overnight whereupon 
6-(I-benzyl-N-nitroso-2-phenyl )ethylamino-l,3-dimethyl-
pyrimidine-2,4-dione was obtained, m.p. 121-122 0 
(Found: C,66.2; H,6.2; N,14.5. C21H22N403 
requires: C, 66.7; H, 5.8; N, 14.8%). The i.r. 
spectrum showed the absence of an -NH- band and the lack 
of colour in the product was further confirmation that 
N- rather than C-nitrosation had occurred. 
6-Chloro-l,3-dimethyl-5-nitropyrimidine-2,4-dione.--
The nitration of 6-chloro-l,3-dimethyluracil was carried 
out as described by Liao and Chang (1964). 6-Chloro-
1,3-dimethyluracil was added slowly to sulphuric acid 
cooled in ice water. Fuming nitri~ acid (d, 1.50) was 
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then added slowly at such a rate as to hold the temper-
ature below 10 0 . At the end of the reaction the mixture 
was poured onto ice and stirred vigorously. The aqueous 
~ 
layer was extracted with chloroform, the extracts dried 
over sodium sulphate and then evaporated to dryness to 
glve 6-chloro-1,3-dimethyl-5-nitropyrimidine-2,4-dione. 
6-Benzylamino-1,3-dimethyl-5-nitropyrimidine-2,4-dione.--
Benzylamine (12.4 g) was added to a well stirred solution 
of 6-chloro-1,3-dimethylpyrimidine-2,4-dione (13 g) in 
ethanol (150 ml). After 3 h the precipitate was filtered 
off and suspended in water (100 ml) and the mixture 
extracted with chloroform (3 x 25 ml) and the extracts 
dried (sodium sulphate). The solid remaining on evapor-
ation of the chloroform was crystallised from ethanol 
giving the 6-benzylamino-5-nitropyrimidine (11 g), m.p. 
140-141 0 (Found: C, 53.5; H, 4.8; N, 19.2. 
C13H14N404 requires: C, 53.8; H, 4.8; N, 19.3%). 
Reduction of 6-benzylamino-1,3-dimethyl-5-nitro-
pyrimidine-2,4-dione.--A solution of 6-benzylamino-1,3-
dimethyl-5-nitropyrimidine-2,4-dione (5 g) in ethanol 
(250 ml) was hydrogenated to completion over Raney nickel 
catalyst. The product (2.4 g) remaining after removal of 
catalyst and solvent evaporation was 8-phenyltheophylline 
(i.r., n.m.r.). The same purine was identified as 
product when either acid stannous chloride or alkaline 
ferrous sulphate were used as reducing agents for the 
nitropyrimidine. 
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8-Phenyltheophylline.--The melt obtained by fusing 
5,6-diamino-1,3-dimethylpyrimidine-2,4-dione and benzoic 
acid at 180~2000 was cyclised in 9% sodium hydroxide 
solution, as described by Hager et al. (1954), to give 
8-phenyltheophylline, m.p. >350 0 . 
Attempted Transamination of 5,6-diamino-1,3-
dimethylpyrimidine-2,4-dione.--The melt, resulting from 
heating a mixture of the 4,5-diaminopyrimidine (0.2 g), 
benzylamine hydrochloride (0.16 g) and benzylamine (10 ml) 
for 4 h at 150 0 (metal bath), when cooled and triturated 
with water gave 8-phenyltheophylline (0.12 g), m.p. >350 0, 
In crystalline form from acetic acid (Found: C, 60.8; 
H, 4.8; N, 21.6. Calculated for C13H12N402: C, 60.9; 
H,4.7; N,21.9 %). 
6-Benzylamino-1,3-dimethylpyrimidine-2,4-dione.--
Prepared according to the method of Bredereck (1960). 
To a solution of benzylamine (10 g) in ethanol (60 ml) 
was added 6-chloro-1,3-dimethyluracil (7.7 g) and the 
mixture heated under reflux (1.5 h). The residue 
obtained on evaporation was extracted with water (600 ml) 
portionwise and chilled giving colour l ess needles of 
6-benzylamino-1,3-dimethylpyrimidine-2,4-dione (7 g), 
m.p. 148-149 0 (Bredereck 1960: 149 0 ). 
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6-Benzylamino-5-bromo-l,3-dimethylpyrimidine-
2,4-dione. --6-Benzylamino-1,3-dimethy l pyrim i dine-2,4-dione 
(10 g) and anhydrous sodiu m acetate (7.5 g) in cold a cetic 
acid (1250 ml) (ice bath) were stirred and bromine (7 g) 
dissolved in acetic acid (50 ml ) added dropwise. At the 
end of the addition, the reaction mixture was diluted with 
sodium acetate (5 g) in ice water (1 ~ ) causing 
6-benzylamino-5-bromo-1,3-dimethylpyrimidine-2,4-dione 
to precipitate. Recrystallisat i on from carbon tetra-
chloride gave the required product, m.p. 135-136 0 
(Bredereck 1960: 137 0 ). 
Amination attempts with 6-Benzylamino-5-bromo-
1,3-dimethylpyrimidine-2,4-dione. --(a) Wi th aque ous ammonia: 
The 5-bromopyrimidine (0.2 g) in aqueous ammonia solution 
(25 % w/v) was heated under reflux for 4 h. On cooling 
6-benzylamino-1,3-dimethylpyrimidine-2,4-dione (0.12 g) 
(i.r., n.m.r.) was obtained. 
(b) With alcoholic ammonia: Under ref l ux conditions (4 h) 
6-benzylamino-5-bromo-1,3-dimethylpyrim i dine-2,4-dione 
(0.2 g) in saturated ethanolic am monia was converted into 
8-phenyltheophylline (0.1 g). 
9-Benzyltheophylline.--Using the procedure of Blicke 
and Schaaf (1956) 5,6-diamino-1,3-dimethylpyrimidine-2,4-
dione (7.6 g) was condensed with benzyl isothiocyanate 
(6.6 g) and the resulting 5-thioureidopyrimidine cyclised 
to 9-benzyltheophylline-8-thione by heating under reflux 
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ln hydrochloric acid. This product was obtained 
crystalline (4.2 g) from acetic acid. On desulphur-
isation of the 8-thiopurine (1.8 g) with nitrous acid 
and then raising the pH of the solution to 8 with 
aqueous ammonia the required 9-benzyltheophylline 
( 0 .95 g) was obtained as crystals, m.p. 170-171 0 
(Blicke and Schaaf, 1956: 167-169 0 ) from butan-2-ol. 
9-Benzyl-8-benzylthiotheophylline.--A solution of 
9-benzyltheophylline-8-thione (0.5 g) in 5N sod iu m 
hydroxide (10 ml) was treated with benzyl bromide 
(0.4 ml), with stirring. After one hour the product 
was filtered off and recrystallised from methanol to 
give 9-benzyl-8-benzylthiotheophylline (0.44 g), m. p . 
179-181 0 (Found: C, 64.2; H, 5.4; N, 14.1. 
C21H20N402S requires: C, 64.2; H, 5.1; N, 14.2 %). 
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Action of Benzyl bromide on 9-Benzyltheophylline.--
When 9-benzyltheophylline (0.2 g) and benzyl bromide 
(0.15 g) in dimethylformamide (5 ml) were heated under 
reflux for 3 h and cooled, no product was obtained. 
To the solution was added petrole um ether ( b .p.60-80 0 ; 10 ~ l) 
and the mixture left for 24 h. The resulting crystalline 
precipitate was shown to be 7-benzyltheophylline (0.1 g) 
by comparison (m.p., i .r., and n.m.r.) with authentic 
material. 
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Action of Heat on 9-Benzyltheophylline hydrobromide.--
The hydrobromide salt was prepared by evaporating to 
dryness a solution of 9-benzyltheophylline (0.2 g) in 
hydrobromic acid (48%, 3 ml). After leaving the salt 
in dimethylformamide (5 ml) for 2 h under reflux the 
mixture was concentrated and the residue taken up in a 
little water. On adjustment to pH 8 wi th ammonia 
solution a crystalline precipitate (0.1 g) of 
7-benzyltheophylline (m.p., i.r., n.m.r., and t.l.c.) 
was obtained. A small amount of the unchanged 9-benzyl 
isomer was recovered on evaporation of the filtrate. 
When the experiment was repeated using 9-benzyl-
theophylline itself no rearrangement occurred, only the 
starting material was recovered. 
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B. 7,8-DIMETHYL-2-METHYLTHIOPURINE AND INTERMEDIATES 
6-Amino-5-(N-methYl )acetamido-2-methylthio-
pyrimidine.--6-Amino-5-methylamino-2-methylthio-
pyrimidine (0.5 g) in ethanol (5 ml) was treated with 
acetic anhydride and kept at room temperature for 2 h. 
After evaporation the residue was recrystallised from 
ethanol giving 6-amino-5-(N-methyl)acetamido-2-methyl-
thiopyrimidine (0.27 g), m.p. 250-251 0 (Found: 
C,45.8; H,5.5; N,26.5. C8H12 N40S requires: 
C,45.3; H,5.7; N,26.4%). 
7,8-Dimethyl-2-methylthiopurine.--6-Amino-
5-(~-methyl )acetamido-2-methylthiopyrimidine (0.25 g) 
was taken up in dimethylformamide (5 ml) containing 
anhydrous potassium carbonate (0.15 g) and heated 
under reflux for 2 h. The residue remaining after 
evaporation in vacuo was recrystallised from ethanol 
giving 7,8-dimethyl-2-methylthiopurine (0.1 g), m.p. 
197-198 0 (Found: C, 49.8; H, 5.4; N, 28.8. 
C8H10 N4S requires: C, 49.5; H, 5.2; N, 28.8%). 
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c. 2-CYCLOALKYLAMINO-6,9-DIMETHYLPURINES 
AND INTERMEDIATES 
2-Chloro-4-methyl-6-methylamino-5-nitro-
pyrimidine.--6-Methyl-5-nitrouracil, prepared by the 
literature method (Robins, 1956), on treatment with 
phosphorus oxychloride gave 2,4-dichloro-6-methyl-
5-nitropyrimidine (Albert et ~., 1954). Replacement 
of one of the chlorine atoms with methylamine provided 
the required 2-chloro-4-methyl-6-methylamino-5-nitro-
pyrimidine (Brown et al., 1966). 
4-Methyl-6-methylamino-2-(morpholin-4-yl )-5-
nitropyrimidine.--Ethanolic morpholine (7.80 g) was 
added slowly to a stirred ice-cold suspension of 
2-chloro-4-methyl-6-methylamino-5-nitropyrimidine 
(7.00 g) in ethanol (15 ml). During the addition 
of morpholine, the suspension became very thick, and 
ethanol (50 ml) was added. The contents of the flask 
were stirred at 25 0 for 2 h and then chilled, the 
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solid was filtered off and recrystallised from methanol 
giving 4-methyl-6-methylamino-2-(morpho l in-4-yl )-5-
nitropyrimidine (6 g), m.p. 194-195 0 (Found: C, 47.6; 
H, 5.8; N, 27.7. Cl0H15N503 requires: C, 47.4; 
H, 6.00; N, 27.7 %). 
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4-Methyl-6-methylamino-5-nitro-2-(piperidin-1-yl) 
pyrimidine.--Ethanolic piperidine (4.20 g, 2.5 mole) 
similarly with 2-chloro-4-methyl-6~methylamino-5-
nitropyrimidine (4 g) gave 4-methy l -6-methy l amino-
5-nitro-2-(piperidin-1-yl )pyrimidine (3.5 g), m.p. 
166-168 0 (from petroleum ether, b.p. 60-80 0 )(Found: 
C,52.1; H,7.0; N,27.7. 
C,52.6; H,6.8; N,27.9 %). 
C11H17N502 requires: 
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4-Methyl-6-methylamino-5-nitro-2-(pyrrolidin-1-yl) 
pyrimidine. --With ethanolic pyrrolidine (4.40 g) the 
above conditions gave 4-methyl-6-methylamino-5-nitro-
2-(pyrrolidin-1-yl )pyrimidine (4.4 g), m.p. 200-202 0 
(from petroleum ether, b.p. 60-80 0 )(Found: C, 50.7; 
H, 6.4; N, 29.6. C10H15N502 requires C, 50.6; 
H,6.4; N,29.5 %). 
5-Amino-4-methyl-6-methylamino-2-(morpholin-4-yl) 
pyrimidine.--A solution of 4-methyl-6-methylamino-
2-(morpholin-4-yl )-5-nitropyrimidine (2.5 g) in ethanol 
containing Raney nickel was hydrogenated to completion, 
5-amino-4-methyl-6-methylamino-2-(morpholin-4-yl) 
pyrimidine (2.1 g) was obtained after the removal of 
the catalyst and evaporation of ethanol. Recrystallisation 
from petroleum ether (b.p. 60-80 0 ) gave the pure 
aminopyrimidine, m.p. 115-117 0 (Found: C, 53.7; H, 7.6; 
N, 31.6. C10H17N50 requires: C, 53.8; H, 7.7; N, 31.4%). 
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5-Amino-4-methyl-6-methylamino-2-(piperidin-l-yl) 
pyrimidine. --An ethanolic solution of 4-methyl-6-
methylamino-5-nitro-2-(piperidin-1-yl )pyrimidine (2.5 g) 
was likewise reduced to give 5-amino-4-methyl-6-
methylamino-2-(piperidin-1-yl )pyrimidine (1.69 g), 
m.p. 120-121 0 after recrystallisation from petroleum 
ether (b.p. 60-80 0 )(Found: C, 59.7; H, 8.5; N, 32.1. 
C11H19N5 requires: C, 59.7; H, 8.6; N, 31.7 %). 
5-Amino-4-methyl-6-methylamino-2-(pyrrolidin-1-yl) 
pyrimidine.--4-Methyl-6-methylamino-5-nitro-
2-(pyrrolidin-l-yl )pyrimidine (4 g) similarly gave 
5-amino-4-methyl-6-methylamino-2-(pyrrolidin-l-yl) 
pyrimidine (2.7 g), m. p. 127-128 0 (from petroleu m ether, 
b.p. 60-80 0 )(Found: C, 57.8; H, 8.1; N, 33.3. 
C10H17N5 requires: C, 57.9; H, 8.3; N, 33.8 %). 
6,9-Dimethyl-2-(morpholin-4-yl )purine.--5-Amino-
4-methyl-6-methylamino-2-(morpholin-4-yl )pyrimidine (1 g) 
and formic acid (98 %, 15 ml) were heated under reflux for 
2 h ·and the solution then evaporated to dryness. 
Crystallisation of the residue from petroleum ether 
(b.p. 60-80 0 ) gave 6,9-dimethyl-2-(morpholin-4-yl )purine 
(0.55 g), m.p. 151-153 0 (Found: C, 56.3; H, 6.3; 
N, 29.9. C11H15N50 requires: C, 56.6; H, 6.5; N, 30.0 %). 
pK a 3.95 ±0.05 (anal. A 240 nm). 
In like manner were prepared from 1 9 of the appropriate 
2-alkylamino-5-amino-4-methyl-6-methylaminopyrimidine: 
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6,9-Dimethyl-2-(piperidin-l-yl )purine (0.55 g), 
m.p. 122-123° (from petroleum ether, b.p. 60-80°) 
(Found: C,62.2; H,7.1; N,30.7. 
requires: C, 62.3; H, 7.4; N, 30.3 %) 
pK
a 
4.66±0.04 (anal A 240 nm) and 
C12H17N5 
6,9-Dimethyl-2-(pyrrolidin-l-yl)purine (0.5 g), 
m.p. 90-92° (from petroleum ether, b.p. 60-80°) 
84 
(Found: C, 59.5; H, 6.8; N, 31.7. CIIHI5N50.0.25H20 
requires: C, 59.4; H, 7.0; N, 31.5 %). 
2-(Hexahydroazepin-1-yl )-6,9-dimethylpurine.--
Similar procedures with hexahydroazepine in place of 
pyrrolidine gave successively 2-(hexahydroazepin-l-yl)-
4-methyl-6-methylamino-5-nitropyrimidine (67 %), m.p. 
115-117 0 (Found: C, 54.6; H, 7.3; N, 26.5. 
C12H19N502 requires: C, 54.4; H, 7.2; N, 26.4 %); and 
the hygroscopic 5-amino-2-(hexahydroazepin-l-yl )-4-methyl-
6-methylaminopyrimidine (94 %), m.p. 82-84 0 (Found: 
C, 60.2; H, 9.0; N, 29.1. C12H21N5.0.25H20 requires: 
C, 60.1; H, 9.0; N, 29.1 %); and the 2-(hexahydroazepin-
1-yl )-6,9-dimethy l purine (48 %), m.p. 62-64 0 (Found: 
C,63.5; H,7.8; N,28.9. C13H19N5 requires: 
C,63.6; H,7.8; N,28.6 %). 
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6,9-Dimethyl-2-(octahydroazocin-1-yl )purine.--
In a like manner octahydroazocine gave 4-methyl-6-
methylamino-5-nitro-2-(octahydroazocin-1-yl )pyrimidine 
(58%), m.p. 107-109 0 (Found: C, 55.4; H, 7.8; 
N, 24.6. C13H21N502 requires: C, 55.9; H, 7.6; 
N, 25.1%) and on reduction, 5-amino-4-methyl-6-
methylamino-2-(octahydroazocin-1-yl )pyrimidine (72%), 
m.p. 82-84 0 was obtained (Found: N, 26.2. 
C13H23N5.H20 requires: N, 26.2%). This amino-
pyrimidine (1 g) and 98% formic acid (15 ml) when 
boiled under reflux for 4 h and evaporated gave the 
crude formyl derivative which cyclised on heating 
for 40 min in formamide containing a drop of 
concentrated hydrochloric acid. Refrigeration gave 
the octahydroazocinylpurine (34%), m.p. 79-81 0 
(from light petroleum) (Found: C, 63.8; H, 7.9; 
N, 26.8. C14H21N5.0.25 H20 requires: C, 63.7; 
H, 8.2; N, 26.6%). 
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D. 6-AMINO-8-ETHOXYPURINES AND INTERMEDIATES 
4-Amino-6-chloro-5-nitropyrimidine.--4,6-Dihydroxy-
pyrimidine, obtained according to the method of Kenner 
et ~. (1943) was nitrated, using the literature 
conditions (Boon et ~., 1951), and the resulting 
4,6-dihydroxy-5-nitropyrimidine then chlorinated 
(Boon, 1951) to give 4,6-dichloro-5-nitropyrimidine. 
By following the procedure of Segal et ~. (1959) the 
monoamination of 4,6-dichloro-5-nitropyrimidine was 
carried out with methanolic ammonia in tetrahydrofuran 
containing sodium hydrogen carbonate. The required 
4-amino-6-chloro-5-nitropyrimidine was obtained in 
good yield (70%) with a m.p. 155-159 0 (from benzene). 
General procedure for the aminolysis of 4-amino-6-
chloro-5-nitropyrimidine.--One gram of 4-amino-6-chloro-
5-nitropyrimidine was added to n-butanol (20 ml) 
containing the appropriate amine (2 g) as reported 
by Daly et ale (1956). After heating under reflux 
for 1.5 h the solution was cooled, and the product 
filtered off and recrystallised. 
Following this procedure 4-amino-6-anilino-5-
nitropyrimidine, m.p. 211-213 0 and 4-amino-6-
benzylamino-5-nitropyrimidine, m.p. 195-197 0 were 
prepared. 
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4-Chloro-6-methylamino-5-nitropyrimidine.--
Following the method of Brown (1957) 4,6-dichloro-
5-nitropyrimidine was treated with aqueous methylamine 
(25 % w/v) in dioxan at 15-20 0 , to give 4-chloro-6-
methylamino-5-nitropyrimidine, m.p. 147-148 0 
(reported 147-148 0 ). 
4-Amino-6-methylamino-5-nitropyrimidine.--
4-Chloro-6-methylamino-5-nitropyrimidine (2 g) when 
treated with an excess of methanolic ammonia produced 
4-amino-6-methylamino-5-nitropyrim i dine (1.5 g), m.p. 
244-246 0 (reported 242-245 0 ). 
General procedure for reduction of 4-amino-5-
nitro-6-alkylaminopyrimidine.--The pyrimidine (2 g) 
in methanol (150 ml) was hydrogenated to completion 
over Raney nickel at room temperature. The triamines 
obtained were used immediately for condensation with 
the orthocarbonates. 
Condensation of 4,5-diamino-6-anilinopyrimidine 
with tetraethoxymethane.--4,5-Diamino-6-anilinopyrimidine 
(0.2 g) and an excess of tetraethoxymethane were heated 
under reflux for 36 h. The reaction mixture was 
concentrated and refrigerated, and the resulting 
solid treated with IN sodium hydroxide and filtered. 
The filtrate upon acidification gave no product. 
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The solid was dissolved in ethanol and the solution 
treated with ether giving a dark brown solid (0.08 g), 
m.p. 170-172 0 (Found: C, 61.4; H, 5.6. C13H13N50 
1 requlres: C, 61.2; H, 5.1 %). The H n.m.r. was 
quite consistent with this product being 8-ethoxy-9-
phenyladenin~ 8[(CO)250] 1.36(t, C~2CH3)' 
4 . 56 ( q, C H 2 C ~3 ), 6. 83 ( s, N H ), 7. 5 ( s, C 6 H 5 ), and 
8.0(s,2-H). 
Condensation of 4,5-diamino-6-benzylaminopyrimidine 
with tetraethoxymethane.--4,5-0iamino-6-benzylamino-
pyrimidine (0.2 g) was heated (12 h) as above with an 
excess of tetraethoxymethane. After filtering and 
concentration the solution was refrigerated affording 
crystals, m.p. 124-126 0 . The n.m.r. and analysis 
indicated it to be 4-amino-6-benzylamino-5-diethoxy-
methyleneaminopyrimidine (Found: C, 60.0; H, 6.6; 
N, 21.8. 
N, 22.2 %). 
C16H21N502 requires: C, 60.9; H, 6.7; 
Condensation of 4,5-diamino-6-methylaminopyrimidine 
with tetraethoxymethane.--Heating (24 h) 4,5-diamino-6-
methylaminopyrimidine (0.2 g) and an excess of tetra-
ethoxymethane gave a solid which was digested with 
alkali and filtered. 
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The solid upon recrystallisation from ethanol 
gave 8-ethoxy-9-methyladenine (0.08 g, 32 %), m.p. 
230-232 0 (Found: C, 49.4; H, 6.1. C8H11N50 
1 
requlres: C, 49.7; H, 5.7 %). The H n.m.r. 
spectrum was in agreement with the structure of this 
derivative. 8 [ ( CD) 3 SO] 1 . 40 ( t, C li2 C H 3 ), 3. 42 ( s, N Me) , 
4.52(q, CH 2Cli3), 6.65(s, NH) and 8.0(s, 2-H). 
The alkaline filtrate upon acidification gave 
a product presumed to be 8-ethoxy-6-methylaminopurine 
(0.05 g, 18 %), m.p. 209-211 0 (Found: C, 44.9; H, 5.7 ~ 
C8H13NS02 requires: C, 45.5; H, 6.2 %) . 
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New co mpounds in this index are ita l icised. 
PURINE S 
7- Benzyltheophy l line 
8- Benzylt heophy lli ne 
9-Benzyltheophy l line 
9- BenzyZ - 8- benzyZthiotheophyZZine 
8-C ro tyltheophylline 
8-Methy l theophy lli ne 
8-Pheny l theophyl li ne 
? ~ 8-DibenzyZtheophyZZine 
? ~ 8 - DibenzyZxanthine 
? ~ 8 - DimethyZ - 2 -methyZthiopurine 
6 ~ 9 - DimethyZ - 2 - (morphoZin - 4 - yZ ) purine 
6 ~ 9 - DimethyZ - 2 - (octahydroazocin-l-yZ)purine 
6 ~ 9 - DimethyZ - 2 - (piperidin - l - yZ)purine 
6 ~ 9-DimethyZ - 2 - (pyrroZidin - l-yZ)purine 
8- Ethoxy - 9- methyZadenine 
8-Ethoxy - 6- methyZaminopurine 
8- Ethoxy - 9- phenyZadenine 
2-(Hexahydroazepin-l-yZ) - 6 ~ 9 - dimethyZpurine 
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4-Amino-6-anilino-5-nitropyrimidine 
4-Amino-6-benzyZamino-5-diethoxymethyZeneami n o-
pyrimidine 
6-Amino-5-benzyZamino-l~3-dimethyZpyrimidine-
2~4-dione 
4-Amino-6-benzylamino-5-nitropyrimidine 
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6-Amino-5-benzylaminopyrimidine-2,4-dione 69 
6-Amino-5-benzylideneamino-l,3-dimethylpyrimidine-
2,4-dione 67 
6-Amino-5-benzylideneaminopyrimidine-2,4-dione 69 
6-Amino-5-(N-benzyZ)phenyZacetamidopyrimidine-
2~4-dione 70 
4-Amino-6-chloro-5-nitropyrimidine 86 
5-Amino-2-(hexahydroazepin-l-yZ)-4-methyZ-6-methyZ-
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l-yZ)pyrimidine 85 
5-Amino-4-methyZ-6-methyZamino-2-(piperidin-l-yZ)-
pyrimidine 83 
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4-Amino-6-methylamino-5-nitropyrimidine 87 
6-Benzylamino-5-bromo-l,3-dimethylpyrimidine-
2,4-dione 77 
6-BenzyZamino-l~3-dimethyZ-5-nitropyrimidine-
2~4-dione 
6-Benzylamino-l,3-dimethylpyrimidine-2,4-dione 
6-(1-BenzyZ-N-nitro8o-2-phenyZ) e thyZamino-l~3-
dimethyZpyrimidine-2~4-dione 
6-(1-BenzyZ-2-phenyZ)ethyZamino-l~3-dimethyZ­
pyrimi~ine-2~4-dione 
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6-Chloro-1,3-dimethyl-5-nitropyrimidine-2,4-dione 74 
6-Chloro-1,3-dimethylpyrimidine-2,4-dione 73 
2-Chloro-4-methyl-6-methylamino-5-nitropyrimidine 81 
4-Chloro-6-methylamino-5-nitropyrimidine 
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4,5-Diamino-6-benzylaminopyrimidine 
4,5-Diamino-6-methylaminopyrimidine 
2,4-Dichloro-6-methyl-5-nitropyrimidine 
4,6-Dichloro-5-nitropyrimidine 
4,6-Dihydroxy-5-nitropyrimidine 
4,6-Dihydroxypyrimidine 
2-(Hexahydroazepin-l-yl)-4-methyl-6-methylamino-
5-nitropyrimidine 
6-Hydroxy-1,3-dimethylpyrimidine-2,4-dione 
4-Methyl-6-methylamino-2-(morpholin-4-yl)-5-nitro-
pyrimidine 
4-Methyl-6-methylamino-5-nitro-2-{octahydroazocin-
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4-Methyl-6-methylamino-5-nitro-2-{piperidin-l-yl)-
pyrimidine 82 
4-Methyl-6-methylamino-5-nitro-2-(pyrrolidin-l-yl)-
6~Methyl-5-nitropyrimidine-2,4-dione 
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Purine Studies. XVII* 
The Synthesis of 2-Substituted 6,9-Di- and 
6,8,9-Tri-methylpurines as Amplifiers of Phleomycin 
Kul Bhushan/ Desmond J. Brown,A ,B John H. Lister,A 
Lawrence G. StephansonA,c and Fumio YonedaD 
A John Curtin School of Medical Research, 
P.O. Box 334, Canberra City, A.C.T. 2601. 
B To whom correspondence should be addressed. 
C Medical Research Council (Canada) Fellow. 
D Leverhulme Visiting Fellow (1974) from Kumamoto University, Japan. 
Abstract 
2-(6',8',9'-Trimethylpurin-2'-ylthio)acetamide (Ie) and analogous N-substituted acetamides are 
prepared by treatment of 6,8,9-trimethylpurine-2-thione (3a) with an appropriate 2-chloroacetamide. 
6,9-Dimethyl-2-(piperidin-l'-yl)purine (1n) and some 2-polymethyleneamino homologues are made 
by initial amination of 2-chloro-4-methyl-6-methylamino-5-nitropyrimidine (2b) followed by 
reduction of the nitro group and final cycIization with formic acid. Such purines enhance the lethal 
effect of phleomycin on Escherichia coli cultures. 
Previous papers have described how the antibacterial activity of phleomycin 
towards Escherichia coli is potentiated considerably in vitro by the addition of certain 
purines. 1 - 4 However, if such a combination is to be useful in vivo, for example 
against a urinary tract infection, l oxidative metabolism of the purine must be mini-
mized by appropriate substitution; at the same time, this must be consistent with 
the maintenance of high activity. 
Of some seventy purines so far tested, most of those with high in vitro activity 
bore, not only C-alkyl groups to prevent hydroxylation, but also an alkylthio or 
dimethylamino substituent. Although the alkylthiopurine (Ia) underwent extensive 
metabolism in mice to give the corresponding (inactive) sulphoxide (1 b), 2 such 
oxidation was decreased by the addition of an amide grouping to the alkylthio 
substituent. 5 Thus neither the active amide (1c) nor the dimethylaminopurines 
underwent appreciable oxidation at their respective functional groupings. 
To develop this lead, we now record the preparation an d activity of some 6,9-
dimethyl- and 6,8,9-trimethyl-purines bearing at the 2-position either a substituted 
carbamoylmethylthio group or a polymethyleneamino group. 
5-Amino-2-chloro-4-methyl-6-methylaminopyrimidine (2a), prepared by an im-
proved route from 6-methyluracil via the nitropyrimidine (2b), was boiled with 
* Part XVI, J. Chern. Soc., Perkin Trans. 2, 1975, paper 5/699. 
1 Grigg, G. W., Edwards, M. J., and Brown, D. J., J. Bacterial., 1971, 107, 599; Grigg, G. W., 
J. Gen. Microbial., 1972, 70, 221. 
2 Brown, D. J., Jones, R. L., Angyal, A. M., and Grigg, G. W., J. Chern. Soc., Perkin Trans. 1, 
1972, 1819. 
3 Badger, R. 1., Brown, D. 1., and Lister, 1. R., J. Chern. Soc., Perkin Trans. 1, 1974, 152. 
4 Angyal, A. M., Grigg, G. W., Badger, R. J., Brown, D. J., and Lister, 1. R., J. Gen. Microbial., 
1974, 85, 163. 
5 Brown, D. J., and Stephanson, L. G., Aust. J. Chern., 1974, 27, 1"371. 
1 Chnstensen, L. 1'., lVlt:yt:r, 1\... D., in • 
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acetic anhydride to give directly the chloropurine (Id). This reacted slowly with 
sodium hydrogen sulphide to give the thione (3a) previously made 2 by a less con-
venient route; treatment of the thione with chloroacetamide in aqueous sodium 
hydrogen carbonate gave the (purinylthio)acetamide (Ie). The similar use of 
appropriate N-substituted chloroacetamides gave the analogues (If-k); another 
analogue (11) was made from the same purinethione and 2-chloropropionamide and 
:'Ie !'lIe 
R2<~JC~ 
:\' .)Rl 
\le 1\ 
R2CI' 
:'IIeR:'\ I :\,)R1 
Rl R2 Rl R2 
(la) SMe H (2a) Cl :\,H2 
(lb) SOMe H (2b) Cl ~Oz 
(Ie) SCH2CONH2 H (2c) SCHMeCO;-JH2 :\,HAc 
(ld) Cl Me (2d) SCHMeCO:-\Hz :\,H2 
(Ie) SCHzCONH2 Me (2e) :\'(cHzh :\02 
(1£) SCH2COl\Me2 :'lIe (2f) :\'(CH2h :\H2 
(lg) SCH2CO),t:t2 Me (2g) :\(CH2).j :\02 
(lh) SCH2CO?\HMe Me (2h) ?\(cH2L :\,H2 
(Ii) SCH2CON[ (CH2CH2)z0 ] Me (2i) :\(CHZ)6 :\02 
(lj) SCH2CONHCH2CH2OH Me (2j) N(CH2)6 :\H2 
(lk) SCH2CONHPh Me (2k) :-\(CH2h :\02 
(11) SCHMeCONH2 Me (21) :\(CH2h :\H2 
(1m) SPr i Yle (2m) :-J[(CH2CH2)z0] :\02 
(In) N(CH2h H (2n) :\'[( CH2CH2)z0 ] :\H2 
(10) 1"\( CH2).j H (20) ?\l( CH2)s :\HAc 
(lp) N(CH2)6 H 
(lq) 1\(CH2) 7 H 
(lr) :\[(CH2CH2)zOJ Me 
(Is) N(CH2h Me 
:vIe R3 R2 
N=C~H 1'£1' RMel\C:-: 
:'le\ ~ A Me I ~\ )SCH2Rl H2:\ )S.\le 
1"\ N S :\ N :\ 
R 
R Rl R2 R3 R 
(3a) Me (4a) CO:\H2 :\1e H (Sa) H 
(3b) H (-ib) H H :\1e (Sb) Ac 
also by cyclization of the N-(pyrimidin-5'-yl)acetamide (2c), prepared from 5-amino-4-
methyl-6-methylaminopyrimidine-2-thione6 via its derivative (2d). In addition, 
2-(6',8'-dimethylpurin-2'-ylthio)acetamide (4a) was made from the known 2 thione 
(3b); the purine (Im), from the thione (3a); and 7,8-dimethyl-2-methylthiopurine 
(4b), from the known 7 diamine (5a) via its acetyl derivative (5b). 
6 Brown, D. J., Ford, P. W., and Tratt, K. H., 1. Chem. Soc., C, 1967, 1445. 
7 Brown, D . J., J. Appl. Chem., 1955, 5, 358. 
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Treatment of the chloronitropyrimidine (2b) with cold ethanolic piperidine gave 
the piperidinylpyrimidine (2e) which was reduced to the 5-amino analogue (2f). 
In boiling formic acid, this underwent acylation and subsequent cyclization to the 
dimethylpiperidinylpurine (In). The homologous pyrrolidinyl-, hexahydroazepinyl-, 
and octahydroazocinyl-purines (Io-q) were made similarly by the sequences 
[(2b) ---+ (2g) ---+ (2h) ---+ (I 0)], [(2b) ---+ (2i) ---+ (2j) ---+ (I p )], and [(2b) ---+ (2k) ---+ (21) and 
(Iq)] respectively; the morpholinylpurine (Ir), via the pyrimidines (2m) and (2n); 
and the trimethylpiperidinylpurine (1s), by two routes: (a) directly from the chloro-
purine (1 d) and (b) from the 5-aminopyrimidine (2f) via its acetyl derivative (20). 
Values for the biological activity of a selection of the above purines and for several 
unrelated derivatives8 ,9 appear in Table 1. It is evident that some of the amides 
[(Ie), (If), (Ii), (Ij), (11), (4a)] and polymethyleneamino derivatives [(In), (Ir), (1s)] 
have the expected high to very high in vitro activity. Thus they fulfil the first criterion 
for practical use as amplifiers of phleomycin against infections. Their performance 
in respect of the second criterion, viz. resistance to metabolic change, will be reported 
later. 
Table 1. Activities of purines as phieomycin amplifiers 
For definition of adjusted activity (Aad) see ref. 4, which also explains why some values are printed 
in italics 
Purine Act. Aad Purine Act. Aad Purine Act. Aad 
(I c) ++++ 510A (lj) +++ 145 (4a) +++ 265 
(1d) ++ 65 (1k) + 0·2 7-Et-6-Me-2-SMeB ++ 22 
(Ie) +++ 130 (11) ++++ 430 6-Me-2-SMe-8-CF3 c + 0·2 
(If) +++ 290 (lm) + 2 7-Et-6-Me-2-SMe-8-CF3 c + 0·1 
(lg) ++ 20 (1n) ++++ 235 9-Et-6-Me-2-SMe-8-CF3 c + 0·1 
(1 h) ++ 20 (1r) +++ 40 caffeineA ++ 30 
(1 i) +++ 105 (1s) +++ 90 caffeineA ++ 11 
A From ref. 4. B Prep.: ref. 8. C Prep.: ref. 9. 
Experimental 
Analyses were done by the Australian National University Analytical Services Unit. The 
anhydrous compounds (1k), (10), (lq), (2c), (2j), (21) were homogeneous to t.l.c. and paper chromato-
graphy but proved to be too hygroscopic for satisfactory analyses as such: accordingly, each was 
equilibrated in the atmosphere for 12-24 h prior to analysis as the hydrated species described below. 
Melting points were uncorrected. Ionization constants were measured spectrometricallylO.l1 at 
20° without thermodynamic corrections. The n.m.r. spectra were measured in CDCI3 , except where 
indicated otherwise, at 35° and 60 MHz on a Varian T60A instrument with Me4Si as an internal 
standard (chemical shifts in J; J values in Hz); u.v. spectra were recorded in aqueous buffer on an 
SP 1800; and i.r. spectra were measured in Nujol mulls on an SP 200. The method for in vitro 
evaluation of purines as amplifiers of phleomycin against E. coli B has been described in detaiI.4 
2-Chloro-6,8,9-trimethylpurine (1 d) 
Nitric acid (d 1· 5; 125 mJ) was added gradually during 2 h to a stirred solution of 6-methyluracil 
(100 g) in concentrated sulphuric acid (300 mJ), maintained at 5-10°. After a further 2 h at 20-25°, 
8 Fenn, M. D., and Lister, J. H., J. Chem. Soc., Perkin Trans. 1, 1974, 1300. 
9 Fenn, M. D., and Lister, J. H., J. Chem. Soc., Perkin Trans. 1, 1975, 485. 
10 Albert, A., and Serjeant, E. P., 'Determination of Ionization Constants' (Chapman & Hall: 
London 1971). 
11 Perrin, D. D., Aust. J. Chem., 1963, 16, 572. 
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the mixture was poured onto ice (1 kg). The crystalline material was washed with water to give 
6-methyl-5-nitrouracil (93 %) (cf. lit. l2 65 %) . This was converted13 into 2,4-dichloro-6-methyl-5-
nitropyrimidine which underwent methylamination 14 to 2-chloro-4-methyl-6-methylamino-5-nitro-
pyrimidine (2b) [recrystallization of the crude material from light petroleum left an insoluble 
by-product, identified as 4-methyl-2,6-bis(methylamino)-5-nitropyrimidine, m.p. 252° (from ethanol) 
(cf. lit. 1s 228 or 235°; different crystalline form?) (Found: C,42'5; H,5·5; N,35·6. Calc. for 
C7 H llNs0 2: C,42'6; H,5'6; N, 35·5%)] and subsequent reduction 14 to 5-amino-2-chloro-4-
methyl-6-methylaminopyrimidine (2a). This material (4' 3 g) and acetic anhydride (15 ml) were 
boiled under reflux for 6 h. The residue from concentration under reduced pressure was extracted 
with boiling ether. Evaporation of the extracts and recrystallization of the residue from light 
petroleum-methanol gave the chlorotrimethylpurine (63 %), m.p. 171-172° (Found: C, 48· 9; 
H,4'8; N,28·6. CsH 9CIN4 requires C,48'9; H,4'6; N,28·5%). pKa 1·83±0·05 (anal. 
286 nm); u.v. 2max (log e) at pH 7: 214 (4' 37), 245 (3. 60),273 (4' 03); at pH 0: 207 (4' 39),234 (3. 62), 
270 (4'.03),277 (3'97); n.m.r. (Me2SO) 2·58 (s, 8-Me), 2·63 (s, 6-Me), 3·67 (s, 9-Me). 
6,8,9- Trimethylpurine-2(JH)-thione (3a) 
The above chloropurine (3 g) was heated under reflux with aqueous 2M sodium hydrogen sulphide 
(75 ml) for 20 h. The cooled solution was acidified with acetic acic and then evaporated to dryness. 
Crystallization of the residue from water gave the purinethione (52 %), identified with authentic 
materiaF by i.r. and u.v. spectra. 
2-(6',8',9' -Trimethylpurin-2' -ylthio )acetamide (J e) 
The above purinethione (125 mg), 2-cbloroacetamide (85 mg), sodium hydrogen carbonate 
(72 mg) and water (2' 5 ml) were boiled under reflux for 90 min. Refrigeration of the filtered solution 
gave the (trimethylpurinylthio)acetamide (89 %), m.p. 212-213° (from methanol) (Found: C, 47· 5; 
H, 5· 2; N, 27· 8. C1oH13NsOS requires C, 47· 8; H, 5· 2; N, 27· 9 %). M+ 251; vmax ] 680 (C=O). 
N-Substituted 2-(6' ,8',9'- Trimethylpurin-2' -ylthio )acetamides 
The purinethione (0' 97 g), 2-chloro-N,N-dimethylacetamide (0' 61 g), sodium hydrogen carbonate 
(0' 5 g) and water (20 m1) were heated under reflux for 1 h. The oily residue from evaporation under 
reduced pressure was extracted with chloroform. The dehydrated extract was evaporated to small 
bulk and diluted with ether to give N,N-dimethyl-2-(6',8',9'-trimethylpurin-2'-ylthio)acetamide (If) 
(64%), m.p. 194° (from chloroform-ether) (Found: C,51'8; H,6'1; N,25·1. C12H17NsOS 
requires C,51'6; H,6'1; N,25·1%). Vmax 1644 (C=O); n.m.r. 2·58 (s, 8'-Me), 2·70 (s, 6'-Me), 
2· 99 (s, Me of NMe2), 3 ·18 (s, Me of NMe2), 3· 70 (s, 9'-Me), 4·18 (s, CH2). 
The following were prepared similarly. 2-Chloro-N,N-diethylacetamide gave N,N-diethyl-
2-(6' ,8',9' -trimethylpurin-2' -ylthio )acetamide (1 g) (57 %), m.p. 100° (Found: C, 54· 5; H, 6· 8; 
N, 22· 9. C14H21NsOS requires C, 54· 7; H, 6· 9; N, 22· 8 %). Vmax 1641 (C=O); n.m.r. 1·13 (t, 
J7, Me of Et), 1·28 (t, J7, Me of Et), 2·57 (s, 8'-Me), 2·68 (s, 6'-Me), 3·43 (q, J7, CH2 of Et), 
3·50 (q, J 7, CH2 of Et), 3· 67 (s, 9'-Me), 4 ·14 (s, SCH2)' 2-Chloro-N-methylacetamide gave 
N-rnethyl-2-(6' ,8',9'-trimethylpurin-2'-ylthio)acetamide (lh) (64 %), m.p. 197-198° (Found: C, 49· 8; 
H,5'7; N,26·7. Cll H1SNsOS requires C,49'8; H,5'7; N,26·4%). Vmax 1664 (C=O); n.m.r. 
2· 60 (s, 8'-Me), 2· 71 (s, 6'-Me), 2· 76 (d, J 5, Me of NHMe), 3· 69 (s, 9'-Me), 3· 88 (s, CH2), 7.07 
(br s, NH). N-(Chloroacety1)morpholine gave 4-[2'-(6",7",8" -trimethylpurin-2" -ylthio )acetyl]morpholine 
(1i)(75 %),m.p.169° (Found: C,52'1; H,5'9; N,21·7. C14H19Ns02S requires C, 52·3; H,6'0; 
N, 21'8 %) . )lmax 1641 (C=O); n.m.r. 2·58 (s, 8"-Me), 2·70 (s, 6"-Me), 3·64 [s, (CH2)4 of morpho line], 
3·68 (s, 9"-Me), 4·17 (s, CH2). 
2-Chloro-N-(2- hydroxyethyl)acetamide gave N -(2' -hydroxyet hyl)-2-( 6',8',9' -trimethylpurin-2' -yl-
thio)acetamide (lj) (41 %), m.p. 227-229° (Found: C, 48· 9; H, 5· 8; N, 23· 5. C12H 17N s0 2S 
12 Gabriel, S., and Colman, J., Ber. Deut. Chern. Ges., 1901, 34, 1234. 
13 Albert, A., Brown, D. J., and Wood, H. C. S., J. Chern. Soc., 1954, 3832. 
14 Brown, D. J., England, B. T., and Lyall, J. M., J. Chern. Soc., C, 1966, 226. 
1S Goldner, H., and Carstens, E., J. Prakt. Chem., 1961, [4] 12, 242; Cohen, S., and Yincze, A., 
Israel J. Chern., 1964, 2, 1. 
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requires C, 48·8; H,5'8; N,23·7 %). Vrnax 1648 (C=O); n.m.r. (MezSO) 2·51 (s, 8'-Me), 2·56 (s, 
6'-Me), 3·27 (m, CHzCHz), 3·65 (s, 9'-Me), 3·87 (s, SCHz), 8·08 (br s, NH). 
The thiopurine (0' 5 g), a-chloroacetanilide (0 ' 46 g), sodium hydrogen carbonate (0' 25 g) and 
water (10 ml) were boiled under reflux for 2 h. The cooled solution deposited 2-(6' ,8' ,9'-trimethyl-
purin-2'-ylthio)acetanilide (1k)(46%), m.p.195° (frommethanol)(Found: C, 55·8; H, 5·5; N,20·0. 
C16H17NsOS,H2 0 requires C,55'6; H,5'5; N,20·3 %). Vrnax 1668 (C=O); n.m.r. (Me zSO) 
2·51 (s, 8'-Me), 2·57 (s, 6'-Me), 3·62 (s, 9'-Me), 4·08 (s, CH2 ), 7·4 (br m, 5H of Ph), 10·23 (br s, 
NH). 
2-(6',8',9'-Trimethylpurin-2'-ylthio )propionamide (1/) 
(A) 6,8,9-Trimethylpurine-2-thione (195 mg), 2-chloropropionamide (130 mg), sodium hydrogen 
carbonate (100 mg) and water (2' 0 ml) were heated under reflux for 30 min. Refrigeration gave the 
(trimethylpurinylthio )propionamide (31 %), m.p. 228-229 0 (from water) (Found: C, 49'1; H, 5·8; 
N,25·8. CllH1SNsOS requires C,49 ' 0; H,5 ' 8; N,26·0 %). M + 265; Vrnax 1700 (C=O). 
(B) 5-Arnino-4-methyl-6-methylaminopyrimidine-2-thione6 (1' 7 g), 2-chloropropionamide (1. 08 g), 
sodium hydrogen carbonate (0' 93 g) and water (20 ml) were heated under reflux for 30 min. 
Then chloropropionamide (0' 35 g) in water (30 ml) was added and heating was continued for a 
further 40 min. The chilled mixture deposited 2-(5' -amino-4'-methyl-6' -methylaminopyrimidin-2'-
ylthio)propionamide (2d) (65 %), m.p. 201-203 0 (from water) (Found: C,44 ' 6; H,6'2; N,28·9. 
CgH15NsOS requires C, 44· 8; H, 6· 2; N, 29·1 %). M + 241; Vrnax 1670 (C=O). This material (120 mg), 
ethanol (10 ml), and acetic anhydride (60 mg) were boiled under reflux for 10 min. Then more 
anhydride (30 mg) was added and heating was continued for a further 10 min. The residue from 
evaporation was washed with a little water to give 2-(5'-acetamido-4'-methyl-6' -methylaminopyrimidin-
2' -ylthio )propionamide (2c) (90 %), m.p. 205-2060 (from ethanol-light petroleum) (Found: C, 44· 5; 
H,6'0; N,23·6. CllH17NsOzS,0'75HzO requires C,44'5; H,6'3; N,23·6%). M + 283; 
Vrnax 1610, 1680 (C=O). The acetamido derivative (30 mg), potassium carbonate (40 mg) and 
dimethylformamide (5 ml) were stirred at 1200 for 7 h. The residue from evaporation in a vacuum 
was washed with a little cold water to give the (trimethylpurinylthio)propionamide (37 %), identified 
with that from (A) by mixed m.p. 
2_(6' ,8' -Dimethylpurin-2' -ylthio )acetamide (4a) 
6,8-Dimethylpurine-2-thione (3b)Z was treated with chloroacetamide as was its trimethyl homo-
logue above. The resulting (dimethylpurinylthio)acetamide (25 %) had m.p. 264- 2670 (dec.) (from 
methanol-ether) (Found: C,45'4; H,4'7; N,29·3. C9HllNsOS requires C,45'6; H,4'7; 
N,29 · 5 %). M+ 295; Vrnax 1690 (C=O). 
2-Isopropylthio-6,8,9-trimethylpurine (1 m) 
The trimethylpurinethione (100 mg) and isopropyl iodide (170 mg) were stirred in aqueous 
5 % sodium hydroxide (10 ml) at 25 0 • Mter 25, 50 and 75 h, further portions (170 mg) of isopropyl 
iodide were added; at 100 h, the product was filtered off and recrystallized from water (charcoal) 
to give the isopropylthiotrimethy/purine (5~ %), m.p. 1120 (Found: C, 56·2; H, 6·6; N , 24·1. 
CllH16N 4 S requires C, 55·9; H,6 ' 8; N,23·7 %). M+ 236. 
7,8-Dimethyl-2-methylthiopurine (4b) 
Acetic anhydride (3 ml) was added to a solution of 4-amino-5-methylamino-2-methylthio-
pyrimidine (5a)? (0' 5 g) in ethanol (5 ml). After 2 h at 25 0 , the mixture was evaporated to give 
N-( 4' -amino-2' -methylthiopyrimidin-5' -y/)-N-methylacetamide (5b) (60 %), m.p. 250-251 ° (from 
ethanol) (Found: C, 45·8; H, 5· 5; N, 26· 5. CSH12N4 0S requires C, 45 · 3; H, 5 · 7; N , 26· 4 %). 
This pyrimidine (0' 25 g), dimethylformamide (5 ml) and anhydrous potassium carbonate (0 · 15 g) 
were heated under reflux for 90 min. The cooled mixture was filtered, diluted threefold with water 
and evaporated to give the dimethylmethylthiopurine (32 %), m.p. 197- 198 0 (from ethanol) (Found : 
C,49'8; H , 5'4; N,28·8. CSH10N4 S requires C,49'5; H,5'2; N,28·8 %). (It is evident that 
an isomeric N,8-dimethyl-2-methylthiopurine of m.p. 158-1590 was incorrectly suspected16 of 
having the above structure.) 
16 Brown, D. J., and Ford, P. W., J. Chem. Soc., C, 1969, 2620. 
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6,9-Dimethyl-2-(piperidin-1' -yl)purine (l n) 
Piperidine (5'1 g) in ethanol (10 ml) was added slowly to a stirred suspension of the above 
2-chloro-4-methyl-6-methylamino-5-nitropyrimidine (2b) (4'07 g) in ethanol (lOml) maintained at 
c. 5°. After a further 2 hat 20-25°, 4-methyl-6-methylamino-5-nitro-2-(piperidin-1'-yl)pyrimidille (2e) 
(92 %) was filtered off. Recrystallized from ethanol and then light petroleum, it had m.p. 166-1680 
(Found: C,52'1; H,7'0; N,27·7. CllH17NsOz requires C,52'6; H,6'8; N,27·9%). This 
nitro compound (4' 65 g) was hydrogenated at atmospheric pressure in methanol (600 ml) at 200 
over Raney nickel. Evaporation of the filtered solution gave 5-amino-4-methyl-6-methylamino-2-
(piperidin-l'-yl)pyrimidine (2f) (73 %), m.p. 121-124° (from light petroleum) (Found: C, 59· 7; 
H,8'5; N,32·1. CllH19NS requires C, 59'7; H,8'6; N,31·7%). This 5-aminopyrimidine (1 g) 
and formic acid (98 %; 15 ml) were heated under reflux for 2 h. The residue from evaporation 
crystallized from light petroleum to give the dimethylpiperidinylpurine (53 %), m. p. 122-123 ° (Found: 
C,62'2; H,7'1; N,30·7. C12H17NS requires C,62'3; H,7'4; N,30·3%). pKa 4'66±0'04 
(anal. ), 240 nm). 
6,9-Dimethyl-2-(pyrrolidin-1' -yl)purine (l 0) 
2-Chloro-4-methyl-6-methylamino-5-nitropyrimidine (4'4 g) in ethanol (150 ml) was treated with 
pyrrolidine (5 g) (as for the piperidinyl homologue above) to give 4-methyl-6-methylamino-5-nitro-2-
(pyrrolidin-l'-yl)pyrimidine (2 g) (86 %), m.p. 200-202° (from light petroleum) (Found: C, 50· 7; 
H,6'4; N,29·6. CloHlSNsOz requires C,50'6; H,6'4; N,29'5%) which underwent hydro-
genation to yield 5-amino-4-methyl-6-methylamino-2-(pyrrolidin-1'-yl)pyrimidine (2h) (78 %), m.p. 
127-128° (from light petroleum) (Found: C,57'8; H,8'1; N,33·3. ClOH17NS requires C, 57.9; 
H, 8· 3; N, 33· 8 %) and subsequent cyclization with formic acid to the dimethylpyrrolidinylpurine 
(45 %), m.p. 90-92° (from light petroleum) (Found: C, 59· 5; H, 6· 8; N, 31· 7. CllH1SNs,0' 25H20 
requires C, 59'4; H,7·0; N,31·5%). 
2-(Hexahydroazepin-1' -yl)-6,9-dimethylpurine (lp) 
Similar procedures with hexahydroazepine in place of pyrrolidine gave successively 2-(hexahydro-
azepin-l' -yl)-4-methyl-6-methylamino-5-nitropyrimidine (2i) (67 %), m.p. 115- 117° (Found: C, 54 · 6; 
H,7'3; N,26·5. C12H19Ns02 requires C, 54'4; H,7'2; N,26'4%); the hygroscopic 5-amino-2-
(hexahydroazepin-1'-yl)-4-methyl-6-methylaminopyrimidine (2j) (94 %), m.p. 82-84° (Found: C, 60·2; 
H, 9· 0; N, 29·1. C12H z1 N s,0' 25HzO requires C, 60'1; H, 9· 0; N, 29·1 %); and the hexahydro-
azepinyldimethylpurine (48%), m.p. 62-64° (Found: C,63'5; H,7'8; N,28·9. C13H 19N S requires 
C,63'6; H,7'8; N,28·6%). 
6,9-Dimethyl-2-(octahydroazocin-1'-yl)purine (lq) 
Likewise octahydroazocine gave 4-methyl-6-methylamino-5-nitro-2-(octahydroazocin-I '-yl)pyrimi-
dine (2k) (58%), m.p. 107-109° (Found: C,55'4; H,7'8; N,24·6. C13H 21Ns02 requires C, 55.9; 
H, 7· 6; N, 25·1 %) and thence, 5-amino-4-methyl-6-methylamino-2-(octahydroazocin-1'-yl)pyrimidine 
(21) (72%), m.p. 82-84° (Found: N,26·2. C13HZ3Ns,HzO requires N,26·2 %). This amino-
pyrimidine (1 g) and 98 % formic acid (15 ml) were boiled under reflux for 4 h. Evaporation gave 
the crude formyl derivative which cyclized on heating for 40 min in formamide containing a drop of 
concentrated hydrochloric acid. Refrigeration gave the octahydroazocinylpurine (34 %), m.p. 79-81 ° 
(from light petroleum) (Found: C,63'8; H,7'9; N,26·8. C14H21Ns,0'25H20 requires C, 63'7; 
H,8'2; N,26·6 %) . 
6,9-Dimethy l-2-(morpholin-4 1 -yl)purine (l r) 
Similarly, morpholine gave 4-methyl-6-methylamino-2-(morpholin-41 -yl)-5-nitropyrimidine (2m) 
(69%), m.p. 194-195° (Found: C,47'6; H,5'8; N,27·7. CloHlSNs03 requires C, 47'4; H,6'0; 
N, 27·7 %); 5-amino-4-methyl-6-methylamino-2-(morpholin-41-yl)pyrimidine (20) (91 %), m. p. 115- 117° 
(Found: C,53'7; H,7'6; N,31·6. C1oH17NsO requires C,53'8; H,7'7; N,31'4 %); and the 
dimethylmorpholinylpurine (52%), m.p. 151- 153° (Found: C,56'3; H,6'3; N,29·9. Cll H15 NsO 
requires C, 56· 6; H, 6· 5; N, 30· ° %). pK4 3·95 ± 0· 05 (anal. ). 240 nm). 
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6,8,9- Trimethy l-2-(piperidin-1' -y l)purine (J s) 
(A) 2-CWoro-6,8,9-trimethylpurine (1d) (197 mg), piperidine (0, 2 ml) and ethanol (10 ml) were 
heated for 30 h in a sealed tube at 100- 110°. The residue from evaporation was extracted with 
hot benzene and the clarified extract was evaporated to give the trimethylpiperidiny lpurine (21 %), 
m.p. 112° (from light petroleum) (Found: C,63'7; H,7 ' 7; N , 28·5. C13H1 9NS requires C, 63·6 ; 
H,7'8; N,28 · 5 %). M + 245. 
(B) 6-Amino-4-methyl-6-methylamino-2-(piperidin-1 '-yl)pyrimidine (2f) (220 mg), acetic anhydride 
(125 mg) and benzene (10 ml) were stirred at 20° for 30 min. The residue from evaporation was 
dissolved in water and decolorized. Evaporation of the aqueous solution gave N-[4'-methyl-6'-
methy lamino-2'-(piperidin-l"-yl)pyrimidin-5'-yl]acetamide (20) (89 %), m.p. 169- 170° (from cyclo-
hexane) (Found : C,59'4; H,7'3; N,26 · 6. C13H21NsO requires C,59'3 ; H,8'0; N,26 · 6 %). 
M + 263 ; Vmax 1680 (0:0). The above pyrimidine (26 mg), aqueous 5 % sodium hydroxide (1 ml) , 
and ethanol (2 ml) were heated under reflux for 5 h. The solution was adjusted to pH 3 with 2M 
hydrocWoric acid and then evaporated to give the trimethylpiperidinylpurine hydrochloride (53 %), 
m.p. 259- 260° (sealed tube) (from ethanol- ether) (Found: C, 55'5; H, 7·2; N, 24·6. C13H 19Ns,HCI 
requires C, 55'4; H,7'2; N,24·9 %). 
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Abstract 
Alkylation of theophylline in aqueous alkaline solution with benzyl halides gives, in addition to the 
expected N 7 benzylated derivative, both 8-benzyl- and 7,8-dibenzyl-theophylline. Synthetic routes to 
these derivatives have been explored and unusual reactivity associated with benzyl groups in some 
of the intermediates has been demonstrated. Results which do not preclude the possibility that benzyl 
radicals could be responsible for the 8-benzylation reaction have been obtained. 
Introduction 
One currently held view on the mechanism of carcinogenesis is that carcinogens 
in vivo are alkylating (or arylating) agents which interact with the purine bases, 
adenine and guanine, in nucleic acid. Evidence which supports this theory is that 
from both in vivo and in vitro experiments with aromatic carcinogens have been isolated 
adducts of guanine in which the carcinogen moiety is covalently linked to C 8 of the 
purine. To explain this, both radical and ionic forms of the carcinogen have been 
proposed as being the species actually interacting with the purine. Recently a number 
of papers! have dealt with the former aspect; in these the isolation of 8-alkylpurines 
is described from reactions in which alkyl radicals were generated by various means. 
On the other hand, two reports have appeared in which 8-alkylation has occurred 
under conditions which favoured ionic rather than radical type mechanisms. Both 
cases resulted from attempted N 7 alkylation of the anionic form of theophylline (1). 
° 
:x
H 
MeN N o~ · 1 ) 
N N 
:]:
0 rH2Ph 
MeN N O~N I) 
° 
:]:
H 
MeN N O~ I }-CH, Ph 
N N 
Me Me Me 
(1) (2) (3) 
* Part XVII, Aust. J. Chem., 1975, 28, 2553. 
1 Christensen, L. F., Meyer, R. B., Miller, J. P., Simon, L. M., and Robins, R. K., Biochemistry, 
1974,14, 1490; Maeda, M., Nushi, K., and Kawazoe, Y., Tetrahedron, 1974,30,2677 ; Leonov, D. , 
and Elad, D., J. Am. Chern. Soc. , 1974,96,5365; J. Org. Chern. , 1974, 39, 1470; Jerumanis, S. , 
and Martel, A., Can. J. Chern. , 1970,48, 1716. 
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Thus, when crotyl bromide was used only 8-crotyltheophylline2 was obtained whereas 
with benzyl chloride a product, claimed to be 8-benzyltheophylline, was isolated 3 in 
addition to the expected 7-benzyl derivative (2). 
Results and Discussion 
In view of the discrepancies between the physical data given for the 8-benzyl 
derivative, noted above, and authentically prepared4 8-benzyltheophylline (3) we re-
peated the benzylation of theophylline, following the published3 conditions. From 
the reaction mixture 7-benzyltheophylline (2) crystallized out but the residue, obtained 
from evaporation of the mother liquors, was separated by preparative t.l.c. into three 
components, two of which were theophylline and more of the 7-benzyl derivative (2). 
° ::l~N~R 
N N 
Me \ 
(4) CH 2Ph 
:C
O FH2Ph 
MeN N o~ I }-CH2Ph 
N N 
Me 
(5) 
Table 1. 1 H n.m.r. spectra of benzylated xanthine derivatives 
6 values in dimethyl sulphoxide 
Xanthine 
1,3-Me2 
7-CH2Ph-l,3-Me2 
8-CH2Ph-1,3-Me2 
9-CH2Ph-1,3-Me2 
7,8-(CH2Ph)2-1,3-Me2 
7,8-(CH2Ph)2 
9-CH2Ph-8-SCH2Ph-1 ,3-Me2 
9-CH2Ph-8-SH 
1,3-Mer8-Ph 
CH2 (benzyl) 
5· 45 (N 7) 
4·05 (C8) 
5· 65 CN 9) 
5· 55 CN7) 
4'10(C8) 
5·37 (N7) 
3·92 (C8) 
5· 50 CN9) 
4· 40 (S) 
5· 83 CN9) 
C6 H 5 
7· 30 
7·31 
7· 30 (m) 
7·17 
7 ·18 
7· 30,7' ° 
7·4 (m) 
8'12,7'48 
Me(N 1), MeCN 3) 
3· 47, 3·25 
3'39,3'19 
3· 41, 3·23 
3 '40,3' 20 
3 '40,3' 20 
3'38,3'23 
3 '40,3' 20 
3· 50, 3·27 
H8 
8·05 
8·27 
7·83 
The analytical data for the remaining product corresponded with those of a dibenzyl-
ated purine, this being confirmed by the presence of two singlets in the 1 H n.m.r. 
spectrum due to two separate sets of benzylic (CH2) protons. A comparison carried 
out with the spectra of the 7-benzyl-, 8-benzyl- and 9-benzyl-theophyllines5 (4; R = H) 
showed that the chemical shifts of the benzylic protons of the 7-benzyl and 8-benzyl 
isomers were in close agreement with the two signals of the dibenzyl derivative 
(Table 1). 
2 Donat, J., and Carstens, E., Chern. Ber., 1959,92, 1500. 
3 Serchi, G., Sancia, L., and Bichi, G., Farmaco, Ed. Sci., 1955, 10, 733. 
4 Hager, G. P., Krantz, J. c., Harmon, J. B., and Burgison, R. M., J. Am. Pharm. Assoc., Sci. Ed., 
1954,43, 152. 
5 Biicke, E. F., and Schaaf, R. L., J. Am. Chern. Soc., 1956, 78, 5857. 
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These findings, together with the absence of any H 8 signal, suggested that the third 
component was 7,8-dibenzyltheophylline (5); the 8,9-dibenzyl isomer (4; R = CH2 Ph) 
was ruled out largely on n.m.r. data which showed that in all 9-benzyl-l,3-dimethyl-
xanthines examined extensive multiplicity and splitting of the phenyl protons signal 
was present in contrast to the singlets found with the 7-benzyl analogues. Confirmation 
of the assignment of (5) followed from a synthesis involving benzylation of 8-benzyl-
theophylline, the product being identical (m.p., i.r., 1 H n.m.r., u.v., and t.l.c.) in all 
respects. The forcing conditions needed to effect alkylation (i.e. benzyl bromide on 
the sodio derivative in dimethylformamide at reflux temperature) would seem to 
indicate some degree of steric hindrance being occasioned by the adjacent 8-benzyl 
and 6-carbonyl groups. In further investigations benzylation of the 7-benzyl purine 
(2), for which anion formation is precluded, was attempted under a variety of condi-
tions. These included benzyl chloride in aqueous sodium hydrogen carbonate (reflux, 
15 h) and dimethylformamide (160°, 6 hand 24 h) but in no case could any dibenzylated 
derivative be isolated, with only starting material being recovered. 
Because it was found that both 7- and 8-benzyl isomers had very similar RF values 
in the systems being used, a re-examination of the 7-benzylated product was made. 
On digestion of this with sodium hydroxide solution and acidifi~ation of the filtrate 
a precipitate of 8-benzyltheophylline was isolated. The claim of the original workers3 
to have obtained 8-benzyltheophylline as the second product of benzylation of theo-
phylline is therefore, in part, correct but in view of the m.p. given, 248-249° (cf. lit.4 
289-290°), we suggest that contamination by both 7,8-dibenzyltheophylline and 
unchanged theophylline was present and that a fortuitous ratio of these in the mixture 
could have given rise to an elementary analysis coincident with that of the mono-
benzylated derivative. 
Attempts at de novo syntheses of either 7,8- or 8,9-dibenzyltheophylline have so 
far been unsuccessful largely due to the unusual benzyl group reactivity shown by 
some key pyrimidine intermediates. For the former purine (5) the 6-amino-5-benzyl-
aminopyrimidine (6; R = CH2Ph) intermediate was obtained, with difficulty, by 
catalytic reduction of the Schiff base derived from the 5,6-diamino derivative (6; 
R = H) and benzaldehyde. All attempts to cyclize (6; R = CH2 Ph) to the 7,8-di-
benzyl purine, using either phenylacetic acid or phenyl acetamide, only resulted in N 5 
debenzylation and formation of 8-benzyltheophylline (3). Even more unexpected 
was the isolation of 8-phenyltheophylline (7) when benzyl cyanide was the cyclizing 
reagent; the mechanism of this reaction still awaits clarification. A more hopeful 
approach, using uracil analogues in the above scheme, gave 6-amino-5-(N-benzyl)-
phenylacetamidouracil (8). Although hot sodium hydroxide treatment converted 
this into 7,8-dibenzylxanthine (9) methylation of this purine to the theophylline 
analogue (5) has not been achieved. 
The attempted preparation of 5-amino-6-benzylamino-l,3-dimethylpyrimidine-
2,4(lH,3H)-dione (lOa), as a precursor of the 8,9-dibenzyl purine (4; R = CH2Ph), 
by various routes gave some unexpected products. Thus, catalytic or chemical reduc-
tion of the 6-benzylamino-5-nitropyrimidine (lOb) gave 8-phenyltheophylline (7) 
through cyclodehydration of an intermediate having a reduced form of the nitro 
group, either the nitroso- or hydroxyamino-pyrimidine, (lOc) or (lOd). Support for 
this is the reported6 isolation of (7) when nitrosation of the 5-unsubstituted 6-benzyl-
6 Goldner, H ., Dietz, G ., and Carstens, E., Justus Liebigs Ann. Chern., 1965, 691, 142. 
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aminopyrimidine (lOe) was carried out in the cold. Two further approaches tried, 
which also gave only the purine (7), were the attempted transamination of the 5,6-di-
amino (6; R = H) analogue with benzylamine hydrochloride and treatment of the 
5-bromopyrimidine (lOf) with ethanolic ammonia. In both of these reactions we 
would suggest a common mechanism operates involving an oxidative cyclization having 
a 5-amino-6-benzylideneaminopyrimidine as intermediate. A noteworthy point was 
the debromination of (lOf) to give (lOe), which occurred with aqueous ammonia; 
only one previous observation of a dehalogenation of this type in a pyrimidine appears 
to have been made. 7 
o 
:;l):NHR 
lte NH2 
(6) 
° 
:J= 
CH?Ph / -
HN N O~N I ;>-CH2Pb 
H 
(9) 
o 
. Ml~~>Ph 
o '-NJ--N 
Me 
(7) 
o 
~R ?v1e1\,-, .~ O~N I\HCH.)Ph 
Me -
(lOa ) R = NH2 
( lOb) R = N02 
(We) R = ~O 
(lOd) R = ~HOH 
(W e) R = H 
(lO f) R = Br 
~?OCH2Ph 
O"N~ l\CH,Ph 
H NH2 
(8) 
o 
?v-lej\ 1\ :J=H O~N I ;>-CH, CH=CHMe 
Me 
(11) 
With the insight gained from the benzylation work we also repeated the crotyl 
bromide alkylation. The results of this confirmed the original workers' findings,2 
8-crotyltheophylline (l1) being the sole product obtained; no trace of the 7-crotyl 
isomer was detected. 
Benzylation with Irradiation 
In the preceding benzylation of theophylline the purine is reacting in the anionic 
form and charge localization effects in the imidazole ring must render the 8-carbon 
atom more nucleophilic and hence more amenable to carbonium ion attack. Alter-
natively, however, this position is also the most favourable site for radical involvement, 
irrespective of whether the purine is in an ionized state or as the neutral molecule. 
In an attempt to gain some insight into the type of reaction obtaining benzylation 
studies have been initiated, under conditions similar to those given earlier, but in the 
presence of both short (mainly 254 nm) and long (mainly 360 nm) wavelength u.v. 
light. Some preliminary results show that under irradiation the yield of 7-isomer 
decreases to less than half the previous value while the yield of 8-benzyl derivative 
7 Pa ul , A. , and Sen , D ., Indian J. Chem. , 1963, 1, 98. 
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increases tenfold. The significant increase in the yield of 8-benzyltheophylline under 
these conditions could well indicate that radicals are involved in C-benzylation. The 
fact that only trace amounts of the 7,8-dibenzylpurine were detected may reflect the 
steric hindrance at N 7 due to the adjacent C-benzyl group restricting N-alkylation. 
While the early state of this work does not allow anY ,conclusions being drawn regar-
ding the mechanisms involved in dibenzylation of theophylline, the results thus far 
do not preclude the idea of an initial 8-benzylation taking place as a result of radical 
attack, with an ionic alkylation at the 7-position then following under the thermal 
conditions existing. 
Results of the irradiation work will be reported in more detail elsewhere when the 
studies are completed. 
Experimental 
Analyses were performed by the Australian National University Analytical Services unit. The 
n.m.r. spectra were measured in dimethyl sulphoxide at 35° and 60 MHz on a Varian T60A instrument 
with Me4Si as an internal standard (chemical shifts in 6) and i.r. spectra were measured in Nujol 
mulls with a Unicam SP 1000 spectrophotometer. The u.v. source in the irradiation experiments was 
a 128-W Oliphant chamber reactor equipped with interchangeable short (254 nm) or long (365 nm) 
wavelength lamps. 
Benzylation of Theophylline 
To a solution of theophylline (5 g) and sodium hydrogen carbonate (2 ' 3 g) in water (100 ml) was 
added benzyl bromide (4' 7 g) and the mixture heated under reflux for 4 h. The crystalline product, 
which separated on cooling, was stirred with 1 N sodium hydroxide solution, filtered and recrystallized 
from ethanol giving 7-benzyltheophylline, m.p. 156- 157° Oit.s 158°). Acidification of the alkaline 
filtrate (pH 5) with acetic acid gave a precipitate of 8-benzyltheophylline (0 ' 07 g), m.p. 289- 290° 
(lit.4 289-290°). The ethanolic mother liquors from recrystallization of the 7-benzyl derivative were 
evaporated and the residue taken up in CHCl 3 and applied to a preparative t.1.c. plate (Merck type 60 
silica) and run in ethyl acetate. Extraction of the lower of the two main bands with hot chloroform 
gave more of the 7-benzyl isomer (total yield 2· 30 g) while from the upper band 7,8-dibenzyltheo-
phylline(5)(0·04g),m.p.120-121 °,wasrecovered(Foupd: C,70'3; H,5 ' 7; N,15 ·9. C21H20N402 
requires C, 70·0; H, 5 · 5; N, 15·5 %). Evaporation of the aqueous filtrate from the original reaction 
mixture gave only unchanged theophylline (0' 67 g). Virtually identical yields of the 7-, 8- and 
7,8-benzylated derivatives, to those given above, were formed when the sodium salt of theophylline 
and benzyl bromide reacte<;i in water at 100°. In addition to the melting points further confirmation 
of 7- and 8-benzyltheophyllines was obtained from their spectral comparisons (i.r., 1 H n.m.r.) with 
those of authentic specimens. 
6-Amino-5-benzylamino-l,3-dimethylpyrimidine-2,4(1H,3H)-dione (6; R = CH2 Ph) 
(A) A solution of 6-amino-5-benzylideneamino-l,3-dimethylpyrimidine-2,4(1H,3H)-dione9 (5 g) 
in ethanol (150 ml) was hydrogenated over Raney nickel until hydrogen uptake was completed. 
After removal of the catalyst and evaporation of the solvent the residue was crystallized from ethanol 
giving 6-amino-5-benzylamino-l,3-dimethylpyrimidin~-2,4(1H,3H)-dione (3' 5 g), m.p. 184-1 86° 
(Found: C,60;2; H,5 ' 8; N,21 ·8. C13H16N402 requires C, 60·0 ; H,6'2 ; N,21·5 %). 
(B) Following Sugimoto and Matsuura's method10 a mixture of 5,6-diamino-l,3-dimethyl-
pyrimidine-2,4(IH,3H)-dione (5 g) and benzaldehyde (3' 4 g) in ethanol (150 ml) when hydrogenated 
under the foregoing conditions also gave the same 6-amino-5-benzylaminopyrimidine (m.p., i. r., 
n.m.r.). 
STraube, W., Justus Liebigs Ann. Chem., 1923, 432, 266. 
9 Traube, W., and Nithack, W., Ber. Dtsch. Chem. Ges., 1906, 39, 227. 
10 Sugimoto, T., and Matsuura, S., Res. Bull., Dep. Gen. Ed., Nagoya Univ., Jpn, 1968,12,24. 
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7-Benzyltheophylline (2) 
After heating a solution of the above 5-benzylamino derivative (0, 2 g) in formic acid (98 %, 15 ml) 
under reflux for 4 h and evaporation only the N-benzyl(pyrimidin-5-yl)formamide was obtained. 
The crude product was taken up in formamide (5 ml) containing hydrochloric acid (0'1 ml) and 
heated at 1700 (oil bath) for 1 h then evaporated to dryness. On crystallization of the residue from 
ethanol 7-benzyltheophylline (0, 1 g) was obtained, identical (m.p., i.r.) with that derived from benzyl-
ation of theophylline, described above. 
8-Benzyltheophylline (3) 
(A) A mixture of 6-amino-5-benzylamino-l,3-dimethylpyrimidine-2,4(lH,3H)-dione (0'1 g) and 
phenylacetic acid (0' 06 g) was heated at 200 0 (Wood's metal bath) for 2 h. The product on cooling 
was 8-benzyltheophylline, m.p. 285 0 (lit.4 289 0 ), from ethanol. 
(B) The above product (m.p., i.r.) also resulted when the 6-amino-5-benzylaminopyrimidine and 
phenylacetamide were fused together (250 0 ) either for short (5 min) or long (3 h) periods. 
7,8-Dibenzyltheophylline (5) 
The sodio derivative of 8-benzyltheophylline, prepared by evaporation of a solution of the purine 
(1 g) in IN sodium hydroxide (9 ml) and water (25 m1), was heated (oil bath) with benzyl chloride 
(0 ' 8 ml) in dimethylformamide (25 ml) under reflux for 4 h. After removal of the solvent the residue 
was crystallized from ethanol to give 7,8-dibenzyltheophylline (0' 7 g), identical (m.p., i.r., n.m.r.) 
with that previously described. 
6-Benzylamino-l ,3-dimethy l-5-nitropyrimidine-2,4(JH,3H)-dione (JOb) 
Benzylamine (12'4 g) was added to a well stirred solution of 6-chloro-1,3-dimethylpyrimidine-
2,4(1H,3H)-dionell (13 g) in ethanol (150 ml). After 3 h the precipitate was filtered off and suspended 
in water (100 ml) and the mixture extracted with chloroform (3 x 25 m!) and the extracts dried 
(Na2S04)' The solid remaining on evaporation of the chloroform was crystallized from ethanol 
giving the6-benzylamino-5-nitropyrimidine (11 g),m.p.140-141 ° (Found: C, 53'5; H,4·8; N,19·2. 
C13H14N404 requires C, 53·8; H,4·8; N,19·3 %). 
8-Phenyltheophy lline (7) 
(A) The melt, resulting from heating a mixture of the 4,5-diaminopyrimidine (6; R = H) (0, 2 g), 
benzyl amine hydrochloride (0' 16 g) and benzylamine (10 ml) for 4 h at 1500 (metal bath), when 
cooled and triturated with water gave 8-phenyltheophylline (0·12 g),z .9 m.p. > 350 0 , in crystalline 
Jormfromaceticacid(Found: C,60'8; N,4'8; H,21·6. C13H12N402requiresC,60'9; H,4'7; 
N,21·9 %). 
(B) A solution of 6-benzylamino-1 ,3-dimethyl-5-nitropyrimidine-2,4(l H,3H)-dione () g) in ethanol 
(250 ml) was hydrogenated to completion over Raney nickel catalyst. The product (2 ' 4 g) remaining 
after removal of catalyst and solvent evaporation was 8-phenyltheophylline (i.r., n.m.r.). The same 
purine was identified as product when either acid stannous chloride or alkaline ferrous sulphale was 
used as reducing agent for the nitropyrimidine. 
(c) Under reflux conditions (4 h) 6-benzylamino-5-bromo-1,3-dimethylpyrimidine-2,4(1H,3H)-
dione12 (l0f) (0 ' 2 g) in saturated ethanolic ammonia solution was converted into 8-phenyltheophyl-
line (0 ' 1 g). 
(D) When 6-amino-5-benzylamino-1,3-dimethylpyrimidine-2,4(1H,3H)-dione (6; R = CH2Ph) 
(0 ' 1 g) and benzyl cyanide (10 ml) were heated at 2700 for 4 h, then cooled, a yellow solid emerged, 
identified by i.r. and n.m.r. as 8-phenyltheophylline. 
N-(4-Amino-2 ,6-dioxo-I,2,3,6-tetrahydropyrimidin-5-y l)-N-benzylphenylacetamide [6-Amino-5-(N-
benzyl)pheny lacetamidouracil] (8) 
Under fusion conditions (230 0 , 4 h) 6-amino-5-benzylaminouraciI8 (0 ' 1 g) and phenylacetic acid 
(0' 72 g) gave the pheny lacetamido derivative (0 ' 6 g), m.p. > 300", obtained pure by reprecipitation 
11 BUhler, E. , and Pfleiderer, W., Chem. Ber. , 1966,99,2997. 
12 Bredereck, H ., Herlinger, H., and Resemann, W., Chem. Ber., 1960, 93, 236. 
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from alkali with acetic acid (Found: C,65'1; H,5'0; N,15·5. C19H1SN403 requires C,65'1; 
H,5·1; N,16·0%). 
7,8-Dibenzylxanthine (9) 
Heating a solution of the foregoing 5-(N-benzy1)phenylacetamido derivative (1 g) in 2 N sodium 
hydroxide for 8 h, followed by neutralization with acetic acid (pH 6), gave 7,8-dibenzylxanthine (0' 5 g), 
m.p. 270° (dec.) (Found: C,66'9; H,4'9; N, 16·2. C19H16N402,-!H20 requires C, 66'9; H,5'0; 
N,16·4%). 
9-Benzyl-8-benzylthio-l,3-dimethylxanthine (4; R = SCH2 Ph) 
A solution of 9-benzylxanthine-8-thiones (4; R = SH) in 5 N sodium hydroxide (10 ml) was treated 
dropwise with stirring with benzyl bromide (0' 4 ml). After stirring for 1 h the precipitate was removed 
and crystallized from aqueous ethanol giving the 8-benzylthio derivative (0'44 g), m.p. 179- 181 ° 
(Found: C,64'2; H,5'4; N,14·1. C21H20N402SrequiresC,64'2; H,5'1; N,14·2%). 
Reaction of Aqueous Ammonia with 6-Benzylamino-5-bromo-l ,3-dimethylpyrimidine-2,4(lH,3H)-dione 
The 5-bromopyrimidine (0' 2 g) in aqueous ammonia solution (25 % w/v) was heated under reflux 
for 4 h. On cooling 6-benzylamino-1,3-dirnethylpyrimidine-2,4(1H,3H)-dione6.7 (0'12 g) (i.f., n.m.f.) 
was obtained. 
Action of Crotyl Bromide on Theophylline 
Sodium theophyllinate (1 g) in water (50 ml) was stirred with crotyl bromide (0' 66 g) for 6 h. 
Crystallization of the precipitate from methanol gave 8-crotyltheophylline (0'5 g), m.p. 232-234°; 
n.m.f. (Me2S0) 1 · 60 (m, C-Me), 3· 20, 3· 38 (s, N-Me), 3· 38 (s, CH2), 5· 56 (m, CH=CH). Evapora-
tion of the aqueous filtrate from the reaction mixture gave only unchanged theophylline (0 ·12 g) 
and the methanolic mother liquors from the crystallization were found to contain only minor amounts 
of 8-crotyltheophylline. All the precipitated 8-crotyl purine was alkali soluble, i.e. no 7-alkylated 
isomer was present. This was confirmed by t.1.c. examination of the products. These data, therefore, 
verify the findings of original workers2 for this C-alkylation reaction. 
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